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Abstract 
 Methyltransferases use S-adenosyl-L-methionine (AdoMet) to transfer the one-carbon 
group to nitrogen, carbon, oxygen, and sulfur nucleophiles, among other atoms. AdoMet is the 
most common biological methyl donor, and the methyl group is used in numerous biological 
processes such as signaling, metabolism, and gene regulation. The mechanism of transfer has 
been determined to be a bimolecular nucleophilic substitution (SN2) reaction, but the origin of 
the catalytic rate enhancement induced by methyltransferases remains a longstanding point of 
debate. The objective of this dissertation is to explore carbon-oxygen hydrogen bonding and 
sulfur-oxygen chalcogen bonding in several different families of methyltransferases to 
understand the importance of these interactions between active site oxygen atoms and the 
AdoMet sulfonium cation in substrate binding and catalysis. Carbon-oxygen hydrogen bonding 
was probed in two methyltransferase families, the Rossmann-like fold methyltransferase TylM1, 
and the reactivation domain of methionine synthase. Mutation to remove carbon-oxygen 
hydrogen bonding of TylM1 to the AdoMet methylene groups flanking the sulfur atom showed 
slight defects in both binding and catalysis. Furthermore, a second TylM1 active site residue 
involved in carbon-oxygen hydrogen bonding to the methyl group of AdoMet was shown to be 
crucial to enzyme catalysis through its role in binding and aligning both substrates. Carbon-
oxygen hydrogen bonding to active site waters in methionine synthase was manipulated by 
mutation of active site glutamates which coordinated these waters to glutamine resulting in a 
loss of substrate binding and a lesser ability to discriminate substrate from product. In addition 
to carbon-oxygen hydrogen bonding, sulfur-oxygen chalcogen bonding between the AdoMet 
sulfonium cation and the active site of the lysine methyltransferase SET7/9, was found to 
facilitate AdoMet binding, discrimination between substrate and product, and catalysis. These 
x 
results are among the first to establish chalcogen bonding as an important interaction in 
enzymes. Collectively, these studies further reinforce the roles of carbon-oxygen hydrogen 
bonding in substrate binding and catalysis across different methyltransferase families, and 
identifies the significance of sulfur-oxygen chalcogen bonding as a newly discovered interaction 
within these enzymes.
.
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Chapter 1: 
Introduction 
1.1 S-adenosyl-L-Methionine 
S-adenosyl-L-methionine (AdoMet or SAM) is a biological substrate most often 
utilized as a methyl group donor, transferring its one-carbon group to a host of 
nucleophiles, including C, N, O, and S. AdoMet has been cited as the second most 
commonly used biological substrate.1, 2 The molecule is synthesized from adenosine tri-
phosphate and methionine,3 resulting in the formation of a methyl-sulfonium that 
electrophilically activates the methyl group, with the remaining molecule, S-adenosyl-L-
homocysteine (AdoHcy or SAH) acting as a leaving group. Though many years have 
passed since the detailing of the structure, AdoMet still remains a point of study in both 
its binding to methyltransferases and catalytic rate enhancement of up to 1016  caused 
when bound by these enzymes versus comparable reactions in solution.4 
 
Figure 1.1: The structure of AdoMet. 
The portion of the molecule from ATP is shown in black, with the rest of the molecule 
coming from methionine. The methyl group donated is above the sulfur atom and is 
shown in red.  
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1.2 Bonding 
1.2.1 Hydrogen Bonding 
The hydrogen bond is well known within the field of biology,5-7 with early 
characterization of basic biological structures noting their importance. Hydrogen 
bonding is cited by Pauling, in his Nature of the Chemical Bond8, as being first 
mentioned in 19129 in the structure of trimethylammonium hydroxide, shown then as 
possessing a (CH3)3N-H-OH arrangement, in which the hydrogen atom is covalently 
attached to the hydroxide and the additional bond to the nitrogen is weaker and is now 
best described as an OH•••N hydrogen bond. The transient but ubiquitous character of 
hydrogen bonding in water was described in 192010, noting that “the liquid may be made 
up of large aggregates of molecules, continually breaking up and reforming…” and that 
a hydrogen “held between 2 octets constitutes a weak “bond.”” The energetics of 
hydrogen bonding in bulk water is well demonstrated by the differences between the 
boiling points of water and methane (Figure 1.2), especially when related to the trends  
seen among elements in the same periodic column.8 The bond was classified as one 
where a hydrogen was bonded to an electronegative atom, and then was engaged with 
a second electronegative atom in an ionic type bond. The electronegative atoms given 
were fluorine, oxygen, nitrogen, and to a lesser extent, chlorine. The charge on the 
electronegative atom is also an important property that can increase the strength of the 
hydrogen bonding, with a positive charge on the atom acting to increase its 
electronegativity, enhancing the strength of donated hydrogen bonds.8 The various 
attractive and repulsive elements of hydrogen bonding were characterized 
computationally in 197711, with electrostatics shown as the dominant component of 
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attraction, but charge transfer and polarization being important at closer distances to 
help overcome the increasing repulsion term. It was also stated that ionic species have 
greater electrostatic contributions, giving more flexibility in arrangement of donor and 
acceptor than in non-ionic hydrogen bonding. 
 
Figure 1.2: Boiling points12 of comparative small molecules. 
Water (A) and methane (B) boil at greatly different temperatures despite similar 
molecular mass due to the ability of water to form hydrogen bonds. This is also seen in 
acetyl chloride (C) vs. trifluoroacetyl chloride (D) and acetic anhydride (E) vs. 
trifluoroacetic anhydride (F).   
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1.2.2 Carbon-Oxygen (CH•••O) Hydrogen Bonding 
The CH•••O hydrogen bond is analogous to a classical hydrogen bond, and 
Pauling notes the evidence for this is quite clear in the difference of acetic anhydride or 
acetyl chloride and the fluoro-derivatives of those compounds.8 As seen in figure 1.2, 
the boiling points of the hydrogen-containing compounds is much higher, even though 
the molecular weight for these compounds is lower. The apparent difference between 
the two pairs of compounds is that the fluoromethyl group is not able to act as a donor 
for hydrogen bonds that the methyl group would be able to form with either the oxygen 
or chlorine atoms. This interaction shows the attractiveness of the CH•••O hydrogen 
bond in an electron withdrawing environment, with the acid anhydride and acid chloride 
polarizing the methyl C-H bond, increasing the ability to hydrogen bond.13 
CH•••O hydrogen bonding was also observed in small molecule crystal structures 
of the time. Sutor, in solving structures of xanthine compounds such as caffeine, noted 
“short” C-O interaction distances where there were hydrogen positions determined by 
their positioning with respect to the sp2 hybridized carbon atom to which they were 
bonded.14-16 Such an interaction was indicative of a CH•••O hydrogen bond, as the 
interaction distance between the carbon and oxygen atoms was closer than their 
combined van der Waals radii (see figure 1.3). Other groups also noted bonding 
characteristic of CH•••O hydrogen bonding by the overly short interactions between 
ethynyl hydrogens and  carbonyl oxygens, with predicted H•••O distance at ~2.2 Å, 
based on the linear positioning of the alkyne.17, 18 Proposed structures of the helical 
peptides collagen and polyglycine II possessed saw distances that would indicate 
CH•••O hydrogen bonding19-21, and spectroscopic evidence in polyglycine II supported 
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the observation, as evidenced by a blue-shift of C-H stretches.22-24 While the collagen 
structure did not prove to be correct,25 there is clear evidence of CH•••O hydrogen 
bonding between chains in collagen-like structure.26 In 1968, there was a critique of the 
carbon-oxygen hydrogen bonding,27 though work did continue on the CH•••O bond both 
computationally28-30 and spectroscopically.31 The field was aided by the positional 
certainty of small molecule neutron structures, where the hydrogen positions are 
experimentally determined, to examine molecular CH•••O interactions32 and those with 
water33. These reports spurred a return to examining the CH•••O hydrogen bond in 
small molecule crystal structures,34-36 as well as nucleic acids37 and protein structure 
and function.38, 39 Computation studies of CH•••O hydrogen bonding showed that they 
behave similarly to normal hydrogen bonds,13 are important energetically in protein 
structure,40-43 and can be highly energetic in a charged system such as AdoMet.44, 45 
Energies for CH•••O hydrogen bonds can range from ~0.6 kcal/mol for a methane and 
water interaction, up to ~7 kcal/mol/bond for trimethyl sulfonium interacting with the N-
methylacetamide carbonyl.44, 46 A survey of high resolution (< 2.0 Å) AdoMet-bound 
structures in the Protein Data Bank found that CH•••O hydrogen bonding to the AdoMet 
methyl group is common across different classes of methyltransferases.47  
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Figure 1.3: CH•••O hydrogen bonding and van der Waals radii. 
The structure of caffeine with the CH•••O hydrogen bond shown (A).14 The interaction 
distance is shorter than the combined van der Waals radii of oxygen and carbon (B), 
and much shorter than the C•••O distance with an intervening hydrogen atom (C).32 Size 
of circles is roughly to scale of ~0.5 inch to 1 Å. 
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1.2.3 S•••O Chalcogen Bonding 
A chalcogen bond is another bond that has been identified as a possible 
interaction that methyltransferases can have with AdoMet. Chalcogen bonding was 
detailed based on interactions closer than van der Waals radii with chalcogen atoms 
(column 16 elements: O, S, Se, etc.) in small molecule crystal structures.48, 49 In these 
studies of thioethers and sulfonium systems, electron-rich nucleophiles preferentially 
approached the sulfur anti to one of the substituents (Fig 1.4). This interaction is similar 
to halogen bonding, where there exists a more positive ‘σ-hole’ where the σ* 
antibonding orbital is located, generally resulting in interaction angles between 160° and 
180° for the electron donor, the halogen, and the covalently bonded substituent.50, 51 
The chalcogen bond also has a positive region52, and can be a highly attractive 
interaction in the context of a sulfonium system.45 The chalcogen bond may also have 
implications in protein folding, as there is evidence for the enrichment of oxygen atoms 
in close contact with sulfur atoms in methionine residues,53-55 particularly in 
phospholipase A2 where key active site residues are near to structural chalcogen 
bonds.56 AdoMet synthetase contains a possible chalcogen bond to an aspartate, and 
upon mutation of this residue to asparagine an almost 5-fold loss in KM for methionine is 
seen.57 Chalcogen bonding is also present in small molecules, with carbonyl oxygens in 
amide groups forming close contacts with sulfurs,55 and intramolecular S•••O distances 
in multiple drug-like molecules much shorter than the van der Waals radii of the two 
atoms.58 
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Figure 1.4: The geometry of chalcogen bonding and van der Waals radii. 
The electron donor in a chalcogen bond, which is a σ*-bonding interaction, approaches 
from ~160°-180° in relation to one of the bonded substituents, seen represented here as 
an oxygen. The van der Waals interaction distance for a sulfur-oxygen chalcogen bond 
is 3.3 Å, shown above, a sum of 1.8 Å for the sulfur and 1.5 Å for the oxygen.32 Size of 
circles is roughly to scale of ~0.5 inch to 1 Å. 
 
1.3 Methyltransferase Classes 
There are at least nine methyltransferase classes, with seven structurally characterized 
AdoMet-dependent methyltransferase classes bound to AdoMet or AdoHcy.59-61 In a 
survey looking for methyltransferases of the human proteome, 208 genes encoding 
predicted methyltransferases were identified, accounting for about 0.9% of human gene 
products.59 In a survey of AdoMet-bound, <2.0 Å methyltransferase structures in the 
Protein Data Bank, though having diverse protein folds, all structures showed evidence 
of CH•••O hydrogen bonding to the AdoMet methyl group (Figure 1.5).47 There is also 
broad conformational freedom in binding AdoMet, with the methionyl and adenosyl arms 
in different conformations in relation to the central sulfonium, as seen in AdoMet from 
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representative methyltransferases (Figure 1.6). 
1.3.1 Class I: The Rossmann-like Fold 
The Rossmann-like fold methyltransferases are also referred to as the Class I 
methyltransferases, as this was the first fold of methyltransferases crystallized, and they 
remain the largest group of methyltransferases.59 The class was first structurally 
characterized in 1993 with the structure of Hha I DNA cytosine methyltransferase.62 The 
heavily studied catechol O-methyltransferase (COMT) followed shortly in 1994 and gave 
a shape to more than three and a half decades of research into the metabolism of 
neurotransmitters.63,64 The common fold seen in both structures was similar to the 
previously characterized Rossmann fold seen in other nucleotide binding proteins, with 
a seventh strand added to the beta sheet.65 The base of the sheet, along with the alpha 
helices that flank the sheet, form a cleft that binds AdoMet. These enzymes possess a 
wide variety of substrates (such as catechols,64 RNA,66 DNA,67 lysine,68 arginine,69 
histamine,70  and thiopurine71), modifying carbon, oxygen, nitrogen and sulfur 
nucleophiles, and therefore can contain many domains outside of the catalytic core to 
aid in binding as well as signaling and regulation. The amount of diversity seen within 
the Rossman-like fold methyltransferases is demonstrated in a simple comparison of 
two well-studied members: COMT (~180 residues) and human DNA methyltransferase I 
(~1600 residues).67 COMT is composed of the catalytic core, while DNMT1 has roughly 
1100 residues used for purposes outside of catalysis. 
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1.3.2 Class II: The Reactivation Domain of Methionine Synthase 
The second fold of methyltransferase characterized was the C-terminal 
reactivation domain of the larger methionine synthase enzyme. The construct was 
isolated through a tryptic digest of the E. coli enzyme, indicating a stable 
methyltransferase domain as part of the larger enzyme.72 The domain is responsible for 
the reductive methylation of the cobalamin ring when it undergoes an oxidative side 
reaction once every ~2000 productive cycles,73 regenerating the methylcobalamin 
necessary for the production of methionine. The fold, which contains a central anti-
parallel beta sheet surrounded by helices and loops binds AdoMet on a concave face, 
almost appearing to cup the molecule on its surface. This presents the AdoMet with a 
largely open face and extended confirmation allowing the methyl to approach the central 
cobalt contained within the planar B12 cofactor. The enzyme is unique in its role, and as 
such is also unique among AdoMet-dependent methyltransferases containing this fold, 
with no similar methyltransferases in the human genome.59  
1.3.3 Class III: Cobalamin-synthase Methyltransferases 
The precorrin synthase methyltransferases are a small class responsible for the 
methylation of pyrrole rings of corrin precursors. The methyltransferases are 
responsible for placing eight methyl groups during the synthesis of the cobalamin ring, 
and there are homologues that function either in an aerobic or anaerobic context, 
depending on organism.74,75 The structure of this family of methyltransferase also 
contains an alpha-beta-alpha motif similar to the Rossman-like fold enzymes, though 
the number of strands in beta sheet has been reduced to five, and the enzyme has two 
11 
 
of these αβα domains. The AdoMet binds in a groove between the two domains, rather 
than at the base of one of the sheets as in the Class I methyltransferases.75,1 
1.3.4 Class IV: SPOUT Methyltransferases 
The SPOUT methyltransferases, named for SpoU-Trmd, two members of the 
family, are largely tRNA modifying methyltransferases, transferring a methyl group to 2’ 
oxygens of the ribose or nitrogen 1 of adenine and guanine rings,76 with a known 
exception being the methylation of protein arginine residues.77 The family is 
characterized by a Trefoil knot-type fold, with the knot being near the C-terminus of the 
protein and donating several residues to the active site. The AdoMet is bound to the 
protein in a curved manner, with the amino acid end of the molecule bending towards 
the top face of the ribose ring.78 
1.3.5 Class V: SET Domain Methyltransferases 
The SET methyltransferases are the second largest class of methyltransferase, 
and are the next best studied.59 The methyltransferases are protein lysine 
methyltransferases, with most of the enzymes specific for various lysines along the 
histone tails (H3K4, H3K9, K3K27, H3K36, and H4K20), though non-histone lysine 
substrates are known.79 They are named for the Drosophila enzymes Suppressor of 
variegation 3-9, Enhancer of zeste, and Trithorax. Methylation on histone lysines is 
important in gene regulation, with trimethylation of a lysine acting to either repress or 
activate transcription, depending on the site of the lysine.80 The structure of the SET 
domain is composed of 9 beta strands forming 3 sheets with two of the sheets and a 
helix forming a pore through which the methyl group is transferred, as the other side of 
12 
 
the pore is the substrate pocket.81,82 CH•••O hydrogen bonding within the methyl 
transfer pore has been characterized in the SET-domain methyltransferase SET7/9.47, 
83, 84 SET7/9 also exemplifies the ability to methylate non-histone substrates, 
methylating lysine residues on the estrogen receptor,85 the tumor suppressor p53,86 and 
the transcription factor TAF10,87 among many other protein substrates.88 
1.3.6 Class VI: Radical-SAM Methyltransferases 
The Radical-SAM methyltransferases belong to the larger class of Radical-SAM 
enzymes, which make use of AdoMet in the production of the adenosyl radical produced 
by homolytic cleavage of the C-S bond. The characteristic fold of the Radical SAM 
methyltransferases is the TIM barrel fold, with the beta sheets holding the active site in 
the middle of the barrel.89 The methyltransferases also contain the characteristic iron 
sulfur (Fe4-S4) cluster of the Radical SAM family, which is used in radical generation 
from AdoMet to form the adenosyl radical, which is used in methylation of difficult 
nucleophiles in this class.90, 91 The founding member of this class was a novel 
chloramphenicol resistance gene (Cfr) for modifying an adenine ring in the peptide exit 
channel of the ribosome.92 This modification requires the use of AdoMet for both methyl 
transfer as well as radical production, with the methyl being transferred to an internal 
cysteine residue, and the next equivalent of AdoMet generating a radical in the 
substrate, allowing the reaction to proceed through the formation of a better nucleophile. 
The transfer of the methyl group from AdoMet to the internal cysteine residue is 
proposed to proceed in a similar manner to known methylation reactions, with the 
methyl of AdoMet being aligned in a linear manner to the cysteine so that the SN2 
reaction can occur. The second enzyme of this class, RlmN, has been shown to have 
13 
 
dual specificity, methylating carbon 2 of adenine rings in both rRNA and tRNA in E. 
coli.93, 94 
1.3.7 Class VII: Integral Membrane Methyltransferases 
The isoprenylcysteine carboxyl methyltransferase (ICMT) and 
phosphatidylethanolamine N-methyltransferase (PEMT) are integral membrane proteins 
that represent a unique fold of methyltransferase, with the crystal structure of ICMT 
showing a fold largely dictated by the fact that it is an integral membrane protein.60 The 
protein contains five transmembrane helices, and a sixth cytosolic helix which stacks 
against a cytosolic extension of helix 5. S-adenosylhomocysteine is seen bound within a 
pore on the cytosolic side of the transmembrane helices, enabling access to the lipid-
bound substrate. The methylation of the carboxy terminus on the lipidated cysteine is a 
final step of processing on these prenylated proteins, and increases the ability to 
associate with the membrane. PEMT also acts on substrates within the membrane, 
converting phosphatidylethanolamine into phosphatidylcholine.95 
14 
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Figure 1.5: Methyltransferase Class Structures and AdoMet methyl CH•••O interactions. 
Representative enzymes of methyltransferase folds shown. Active site CH•••O 
distances of less than 3.7 Å to the AdoMet methyl group shown as orange dashes. 
Class I is represented by TylM1 (A, PDB: 3PFG).96 Class II is represented by the E. coli 
Methionine Synthase Reactivation domain (B, PDB: 1MSK).72 Class III is represented 
by CobF (C, PDB: 2NPN). Class IV is represented by TrmH (D, PDB: 1V2X).78 Class V 
is represented by SET7/9 (E, PDB: 1N6A).82 Class VI is represented by RlmN, with the 
Iron-Sulfur cluster shown as spheres (F, PDB: 3RFA).89 
 
 
Figure 1.6: Conformations of AdoMet across Methyltransferase Classes aligned by the 
sulfonium. 
AdoMet overlay generated from the six methyltransferases from figure 1.5, with AdoHcy 
from a Class VII enzyme as a representative of that class (PDB: 4A2N).60 Though all 
methyltransferases need to align the C-S bond with the nucleophile for effective 
transfer, there is conformational freedom in how that is accomplished. 
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1.4 Mechanism of Methyl Transfer 
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Figure 1.7: Mechanism for AdoMet methyl transfer. 
The mechanism for the methylation of a catecholate (as the representative nucleophile) 
by AdoMet (without the methionyl and adenosyl arms shown). The reaction proceeds 
with the positive charge on the sulfur partially moving to the carbon as the methyl group 
goes through a carbocation-like transition state of the SN2 mechanism. The transition 
state is roughly planar, and the transfer results in the inversion of the methyl group 
stereochemistry. 
 
Characterization of COMT methylation activity demonstrated substrate 
preference, noting that the reaction is likely a nucleophilic attack on the methyl group of 
AdoMet.64 Further work by Woodward confirmed the inversion of stereochemistry of the 
methyl group upon transfer by COMT, as well as the inversion of stereochemistry on N 
and C methyl transfers carried out by two other enzymes.97, 98 Kinetic isotope effect 
studies were carried out by the Schowen group in 1979 to compare intermolecular and 
intramolecular methyl transfer with the catalysis of COMT.4, 99, 100 These studies showed 
a large inverse kinetic isotope effect with respect to the hydrogens on the methyl group 
(CH3/CD3 = 0.83) leading to the conclusion that it is a tight transition state101, and a 
large isotope effect with respect to the carbon (12C/13C = 1.09) was interpreted as the 
result of a symmetrical transition state.102 This gave rise to one of the explanations of 
the source of catalytic rate enhancement for methyl transfer: the compression model, in 
which the enzyme brings AdoMet and the nucleophile into closer proximity than would 
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be in solution by constraining them.103 Though the compression model has been 
challenged,104-109 it does continue to be an active point of research.110-112 Another pair of 
models for methyl transfer that have been challenged113, 114 are the entropic115 and 
‘cratic’116-118 models, which attribute catalytic enhancement to the enzyme-substrate 
binding energy paying entropic or other penalties that would arise for the transition state 
in solution. There are two other models, Bruice’s Near Attack Conformers (NAC)119, 120 
and Warshel’s Electrostatic Preorganization114, 121-124 The Near Attack Conformer model  
is one in which the enzyme binds the substrates in a manner that favors the formation of 
close proximity conformations, leading to reaction. The Electrostatic Preorganization 
model states that the enzyme electrostatics are arranged to preferentially stabilize the 
transition state, leading to catalytic enhancement. Recent computational and 
experimental work have cited CH•••O hydrogen bonding as factor in the inverse kinetic 
isotope effect seen (CH3/CD3) for the methyl transfer.106, 125 
1.5 Conclusion 
 Though CH•••O hydrogen bonding has become more accepted, the mechanism 
of AdoMet-dependent methyltransferases remains somewhat controversial. In this 
dissertation I set out to further characterize CH•••O hydrogen bonding in non-SET-
domain enzymes, such as the Methionine Synthase Reactivation domain (chapter 2) 
and the Rossmann-like fold methyltransferase TylM1 (chapter 4). I also explore the 
effects that S•••O chalcogen bonding can have on binding and catalysis in bonding with 
the AdoMet sulfonium sulfur in SET7/9 (chapter 3). Through these aims I hope to further 
the understanding of the enzymatic features of AdoMet methyl transfer.
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Chapter 2: 
Water-Mediated Carbon-Oxygen Hydrogen Bonding Facilitates AdoMet 
Recognition in the Reactivation Domain of Methionine Synthase 
Robert J. Fick, Mary Clay, Lucas P. Vander Lee, Steve Scheiner, Hashim Al-Hashimi, 
and Raymond C. Trievel 
 
2.1 Introduction 
Cobalamin-dependent Methionine Synthase, MetH, is a multi-domain protein that 
uses methyl-cobalamin as an intermediate to transfer the methyl group from methyl-
tetrahydrofolate to homocysteine.73, 126, 127 Three separate domains are responsible for 
the binding of methyl-tetrahydrofolate, homocysteine, and cobalamin for the regular 
catalytic cycle.128 The enzyme transfers the methyl group from methyl-tetrahydrofolate 
to the cobalamin cofactor to produce methylcobalamin. The methylcobalamin is then 
used as the methyl donor to form methionine from homocysteine. MetH serves a vital 
role in one-carbon metabolism, with most homocysteine regeneration to methionine 
occurring through MetH catalytic activity; the activity of betaine-homocysteine 
methyltransferase serving as a secondary pathway that occurs in the liver and 
This work is in preparation to be published under the same title 
RJF purified the protein, performed the binding studies, and prepared the isotopically 
labeled AdoMet. RJF and LPV crystallized the protein and refined the structures. SS 
performed the QM analysis. MC performed the NMR experiments. RCT and RJF 
prepared the manuscript 
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kidneys.129 The normal cycling of MetH is also the route for all methyl-tetrahydrofolate to 
enter the folate pool in cells.130 A fourth domain binds S-Adenosyl-L-Methionine 
(AdoMet) and is involved in the reductive methylation of non-catalytic Co(II) cobalamin 
that is formed roughly every 2000 cycles.73 The electron for this reaction comes from 
flavodoxin in E. coli131 and cytochrome b5  in H. sapiens,132 and the favorable 
methylation of cobalamin by AdoMet drives the reaction. The reactivation domain of 
MetH represents a unique fold of AdoMet-dependent methyltransferase, present only in 
the context of the larger enzyme in S. cerevisiae and H. sapiens.59, 61 The domain 
adopts an open, C-shaped conformation, with AdoMet held in a largely open active site 
to facilitate the necessary interaction with the planar B12 cofactor. This unique domain is 
also referred to as class II, as it was the second of the seven structurally characterized 
AdoMet-dependent methyltransferase classes.1, 59 
The crystal structure of the MetH reactivation domain was first solved in 1996,72 
coming shortly after the first, Rossmann-like fold methyltransferases which were 
structurally characterized in 1993.62 AdoMet also adopts a unique, extended 
conformation within the MetH active site, with the C-O distance between the methyl 
carbon and ribose furan oxygen in the 1996 structure at 3 Å. Carbon-oxygen (CH•••O) 
hydrogen bonding to the methyl group of AdoMet has been explored extensively in the 
context of the SET-domain lysine methyltransferase SET7/9.47, 83, 84 As part of these 
studies, a survey of CH•••O hydrogen bonding to the AdoMet methyl was undertaken in 
high resolution (<2.0 Å) AdoMet-bound structures in the Protein Data Bank, in which the 
short, internal C-O interaction in MetH was noted.47 These carbon-oxygen hydrogen 
bonds appear to be a universally conserved feature of AdoMet-dependent 
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methyltransferases, to facilitate binding of AdoMet over the product, S-
adenosylhomocysteine (AdoHcy), as well as aligning the methyl carbon-sulfur bond to 
catalyze the SN2 reaction. MetH presented an interesting case, as direct CH•••O 
bonding to the protein was not seen.  
2.2 Structural Study 
To probe the active site interactions in MetH, the protein was crystallized in 
complex with a variety of ligands (see Table 2.1 for crystallographic statistics). The 
substrate (AdoMet), product (AdoHcy), and a natural product inhibitor sinefungin were 
all found within the active site in a highly similar conformation. Clear density for each 
ligand is seen in simulated-annealing omit maps, along with several waters that are 
constant across the structures (Figure 2.1). The overall conformation of all the 
structures remains highly similar to the 1996 structure, with a RMSD of ≤ 0.32 Å for the 
aligned Cα atoms (Figure 2.2A). The binding cleft of MetH is acidic, with two glutamate 
residues, 1097 and 1128, flanking the sulfonium cation of AdoMet, though not directly 
engaged with it (Figure 2.2B), with the two glutamates noted in the 1996 structure for 
their unpaired charges. Instead, these residues interact through the structured waters in 
the active site, with the active site of MetH largely solvent exposed (Figure 2.2C-E). The 
structured waters engage in classical hydrogen bonds with the two glutamate residues, 
and the waters CH•••O hydrogen bond to methyl, methylene, and methyne carbons of 
AdoMet. The waters and glutamate positions are highly similar across all three ligands 
(Figure 2.2F). Glutamate 1097 binds to the waters labeled W1 and W2, with water W1 
CH•••O hydrogen bonding to the AdoMet methyl (or a classical hydrogen bond to the 
amine of sinefungin) and C4’, and water W2 CH•••O hydrogen bonding to the Cβ 
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carbon. Glutamate 1128 binds the waters, W3 and W4.  Water W3 is able to CH•••O 
hydrogen bond to both the C5’ and Cβ carbons as well as forming a classical hydrogen 
bond with one of the ribose hydroxyls, whereas water W4 is able to CH•••O hydrogen 
bond to the C5’ carbon, though interactions with waters W3 and W4 are not present 
across all the ligands.  
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Figure 2.1: Simulated annealing FO - FC omit maps for AdoMet (A), AdoHcy (B), and 
sinefungin (C) bound to MetH. 
The map is contoured at 2.0 σ. The depicted ligands as well as residues and water 
molecules within 5 Å of the ligands were omitted during the map calculations. For 
clarity, the electron density is shown for the ligands, Glu1097, Glu1128, and the waters 
mediating hydrogen bonding.  
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Figure 2.2 Structural comparisons of MetH bound to AdoMet, AdoHcy, and Sinefungin. 
(A) Cartoon representation of 1MSK and MetH structures from this work superimposed 
by C-alpha atoms, with 1MSK shown in gray, MetH•AdoMet in green, MetH•sinefungin 
in cyan, and MetH•AdoHcy in pink. (B) Electrostatic render of the AdoMet bound active 
site, with the potential contoured between -5.0 (red) and 5.0 (blue) kT/e. The ligand 
superimposition from (A) is also shown, with the positions of the two glutamate residues 
labeled. Bonding patterns shown for the AdoMet-bound (C), AdoHcy-bound (D), and 
sinefungin-bound (E) structures. CH•••O hydrogen bonds shown as orange dashes, 
S•••O chalcogen bonds shown as purple dashes, and classical hydrogen bonds shown 
as cyan dashes.   
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    MetH•AdoMet MetH•AdoHcy MetH•Sinefungin 
PDB Code   6BM5 6BM6 6BDY 
Data Collection     
Wavelength (Å)  0.97903 0.97903 0.97903 
Space group  P212121 P212121 P212121 
Cell dimensions     
   a, b, c (Å)  38.10 61.67 139.92 38.23 61.66 139.95 38.35 61.58 139.88 
   α, β, γ (°)  90 90 90 90 90 90 90 90 90 
Resolution (Å) 
 
34.98  - 1.50      
(1.53  - 1.50) 
30.43  - 1.50      
(1.53  - 1.50) 
32.55  - 1.50      
(1.53  - 1.50) 
Rmerge (%)  6.0 (23.3) 6.5 (33.1) 6.1 (28.0) 
CC1/2  (0.96) (0.92) (0.96) 
<I/σI>  15.72 (4.30) 12.15 (3.10) 14.85 (4.37) 
Completeness  98.5 (88.8) 98.4 (89.3) 98.5 (87.7) 
Redundancy  5.4 (3.7) 4.5 (3.2) 5.9 (4.5) 
     
Refinement     
Resolution  1.50 1.50 1.50 
No. of Reflections  53030 52572 51571 
Rwork/Rfree  0.15/0.19 0.16/0.20 0.14/0.18 
No. of Atoms  3100 3078 3074 
   Protein  2589 2590 2605 
   Ligand/ion  27 26 27 
   Water  484 462 442 
B-factors  23.44 26.29 24.34 
   Protein  21.44 24.54 21.95 
   Ligand/ion  19.1 21.83 18.79 
   Water  34.34 36.33 38.75 
R.M.S. Deviations     
   Bond lengths (Å)  0.007 0.009 0.009 
   Bond angles (°)  0.9 1.02 0.99 
MolProbity Score     
   Percentile  99% 99% 99% 
    Resolution Range (Å)  1.494 ± 0.25 1.504 ± 0.25 1.512 ± 0.25 
Ramachandran     
   Favored (%)  98.45 97.52 98.15 
   Allowed (%)  1.55 2.48 1.85 
Outliers (%)   0 0 0 
 
Table 2.1: Crystallographic and refinement statistics for MetH WT and mutants 
  
26 
 
2.3 NMR Spectroscopic Study 
Chemical shift studies were performed on MetH with 13CH3-methyl AdoMet in a 
2D-HSQC experiment to determine the electronic environment of the AdoMet methyl 
group and to provide a comparison to past results. The original studies of SET7/9 paired 
quantum mechanical studies of NMR chemical shift of the methyl at various rotations 
with experimentally determined chemical shift to provide insight into the methyl rotamer 
position and subsequent CH•••O hydrogen bonding.83  
MetH has a solvent exposed binding pocket, where AdoMet forms no direct 
interaction with active site residues. This should result in much smaller perturbations in 
the 13C and 1H chemical shifts upon binding compared to SET7/9 which forms two 
CH•••O between the AdoMet methyl and Y335 and H293 carbonyl groups. As shown in 
figure 2.3, a substantially smaller chemical shift perturbation is noted for MetH-bound 
AdoMet relative to the solution 1H chemical shift of 2.97 ppm and 13C chemical shift of 
26.0 ppm previously reported.133 Furthermore, we observe a cross peak in the 
SOFAST-HMQC spectra of MetH-AdoMet but not SET7/9-AdoMet. This is consistent 
with the exclusion of water from the SET7/9 binding pocket and solvent accessibility of  
the MetH binding pocket (Figure 2.4), as the SOFAST-HMQC method relies on 
exposure of the excited proton to many non-perturbed protons, reducing the relaxation 
time.134 
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Figure 2.3: Two-dimensional NMR studies of MetH and SET7/9 with 13CH3-methyl 
AdoMet 
Chemical shifts of the AdoMet methyl group in MetH by HSQC (A) and SOFAST-HMQC 
(B). For comparison, the same chemical shift studies were performed on SET7/9, with a 
much greater chemical shift by HSQC (C), and an absent peak in the SOFAST-HMQC 
experiment (D). 
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Figure 2.4: Solvent exposure of the AdoMet methyl group in MetH (A) and SET7/9 (B 
and C, using 4J83).  
Waters within 5 Å show as spheres, and amino acids forming the methyl pore47 in 
SET7/9 shown as gray sticks. 
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2.4 Quantum Mechanical Study and Isothermal Titration Calorimetry 
Direct disruption of the CH•••O hydrogen bonding by mutagenesis was not 
possible in MetH due to the donors being active site waters. However, the charge of the 
two noted glutamate residues could be manipulated through the introduction of a 
glutamine mutation, conserving the hydrogen bonding potential with the neighboring 
waters. Mutation of glutamate to glutamine was explored both quantum mechanically 
with minimal model systems and by isothermal titration calorimetry with various ligands 
(Figure 2.5). The minimal active sites consisted of either S(Et)2, representing the 
product AdoHcy, or MeS+(Et)2, representing the substrate AdoMet. The interaction with 
each glutamate was tested separately to give the clearest interpretation of the energy 
obtained. In both glutamate and glutamine systems, the representative ligand atoms 
were frozen in their respective crystallographic positions. In the glutamate structures, 
the waters were also frozen in their crystallographic positions, while the glutamine 
waters allowed to optimize in position, with the exception of water W4 in the 1128 
AdoHcy model, as this water migrated to a position that would cause a steric clash with 
tyrosine 1189. The glutamates and glutamines were modeled as the sidechain alone, 
with the beta carbons being frozen, and at the 1097 position the gamma carbons were 
also frozen in the crystallographic positions, as the sidechain would pivot on the beta 
carbon to be further underneath the sulfonium and displace the waters. The glutamines 
were modeled in the position of the glutamates, with the amide being placed distal to 
the ligand atoms, such that the carbonyl would still preserve the hydrogen bonding 
pattern of the carboxylate. 
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The calculations were carried out in vacuum (dielectric =1), allowing comparison with 
past results conducted in the same manner. This will show the maximum change in 
energy, as there will be no shielding of charges. 
Isothermal titration calorimetry was used as an in vitro measure of hydrogen 
bonding within MetH, utilizing various ligands to compare the effects of charge removal 
at points in the active site (see Appendix for data). Differences between AdoMet and 
AdoHcy are largely due to loss of charge on the central sulfur atom, influencing the 
strength of bonding to methyl and methylene hydrogen atoms by active site oxygens.44 
Sinefungin, an AdoMet natural product analog in which the sulfur and donated methyl 
group have been substituted for a carbon and an amine group. The trend seen between 
both the binding data and the energy calculations is that the substrate AdoMet more 
energetically binds to MetH than does the product AdoHcy (Table 2.2). The wild type 
has both a larger ratio of KD’s (AdoHcy/AdoMet) and larger difference in energy 
between the AdoMet and AdoHcy minimal systems. The ratio of KD’s in the WT enzyme 
is ~14.6, while either glutamate to glutamine mutation greatly drops the ratio to ~2.5-2.2. 
The energies mirror this trend, with the minimal active sites for glutamates having a 
difference of 79 and 67 kcal between AdoMet and AdoHcy, while the glutamine mutants 
have differences of 12 and 26, respectively. While there is a lesser energy gap between 
the 1128 WT and 1128 E to Q mutant for AdoMet (Table 2.2, ΔEB [E-Q]), it is more 
disruptive to binding, with the KD for AdoHcy doubling and the KD for AdoMet increasing 
by about 12-fold. This is opposed to the 1097 position which has a greater difference in 
the calculated energies, but only a 4-fold loss of AdoMet binding, and a tighter binding 
of AdoHcy upon introduction of the mutation, though the calculated energy difference for 
31 
 
AdoMet between the wild type and glutamine mutant is much larger, as the wildtype has 
a greater binding energy and the mutant a lower binding energy than the respective 
1128 AdoMet models. The divergence of KD disruption and calculated energies is 
probably due to the interactions of 1097 and 1128 with the ligand, with 1097 largely 
encompassed by the interactions in the minimal model, while 1128 also interacts 
through a water with a ribose hydroxyl of the ligand that is not represented in the 
minimal model to avoid ascribing energy from that interaction to CH•••O hydrogen 
bonding. The charge would be expected to increase the hydrogen bonding strength to 
ribose hydroxyl as well,11 causing the loss of both AdoHcy and AdoMet binding. 
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Figure 2.5: MetH quantum mechanical minimal models. 
All ligand atoms (representing AdoMet and AdoHcy) were frozen, with other frozen 
atoms denoted by asterisks on those atoms. Models representing AdoMet (shown in 
green) complexed with glutamate 1097 (A), glutamate 1128 (B), glutamine 1097 (C), 
and glutamine 1128 (D). Models representing AdoHcy (shown in pink) complexed with 
glutamate 1097 (E), glutamate 1128 (F), glutamine 1097 (G), and glutamine 1128 (H). 
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    KD (μM) 
    WT   E1097Q   E1128Q 
AdoMet  1.43 ± 0.05  6.10 ± 0.68  17.5 ± 1.0 
AdoHcy  20.8 ± 0.2  15.0 ± 0.5  38.2 ± 1.0 
Sinefungin  2.04 ± 0.07  17.7 ± 1.56  44.8 ± 2.51 
    ΔH (kcal mol-1) 
    WT   E1097Q   E1128Q 
AdoMet  -23.92 ± 0.10  -19.43 ± 0.16  -15.65 ± 0.09 
AdoHcy  -15.30 ± 0.03  -11.95 ± 0.04  -11.22 ± 0.04 
Sinefungin  -18.59 ± 0.09  -17.02 ± 0.17  -14.63 ± 0.13 
  QM binding energies (kcal mol-1) 
  E1097 Q1097 ΔEB [E-Q] E1128 Q1128 
ΔEB [E-
Q] 
MeS+(Et)2  complex energy 87.69 19.19 68.50 73.41 29.30 44.11 
S(Et)2  complex energy 8.45 7.25 1.20 6.30 3.53 2.77 
ΔEB [MeS+(Et)2 - S(Et)2] 79.24 11.94   67.11 25.77   
 
Table 2.2: ITC data and QM calculated binding energies for the various ligands with 
MetH WT, E1097Q, and E1128Q.  
Differences in energy between the glutamate and glutamine models, giving an 
estimation of lost interaction energy upon mutation, shown as ΔEB [E-Q], and 
differences in the binding energy between the AdoMet-like model and the AdoHcy-like 
models, giving an estimation of the ability to selectively bind substrate over product, 
shown as ΔEB [MeS+(Et)2 - S(Et)2]. 
 
2.5 Discussion 
MetH represents a unique fold of methyltransferase and possesses a unique 
method of binding to AdoMet, binding the sulfonium system exclusively through waters 
within the active site. MetH is also an enzyme of great metabolic importance since it is 
the enzyme at the center of one-carbon metabolism within the cell.130 Though the 
enzyme characterized in this study was the E. coli enzyme, the H. sapiens enzyme is 
highly similar, with a key difference of a leucine (L1166) in the human enzyme in 
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position of glutamate 1128 that we explored in the E. coli enzyme.135 This would be 
expected to decrease the substrate/product discrimination of the enzyme based on the 
results of the glutamine mutation at that position. The difference in the human enzyme, 
coupled with the binding affinities of sinefungin relative to AdoMet, causes some 
concern with respect to sinefungin analogs. Sinefungin has been used as a scaffold for 
inhibitor development,136 but with the open active site of MetH, these compounds may 
be accommodated and cause inhibition of the enzyme. This in turn could disrupt the 
AdoMet/AdoHcy balance, which is between 2-11 fold normally,137, 138 and cause further 
inhibition of the enzyme by high AdoHcy levels, with implications for global methyl flux. 
Screening of AdoMet-like inhibitors may be aided by study of their binding to MetH, in 
an effort to stem possibly cytotoxic effects. 
2.6 Materials and Methods 
AdoMet purification 
Isotopically-labeled AdoMet was produced enzymatically using E. coli AdoMet 
synthetase (MetK)139, 140 similar to a previously described method.3 The sequence for 
MetK was used in an expression vector, pHT4 (based on pET15b, Novagen) with 
Tobacco etch virus (TEV) protease cleavable N-terminal His-tag to aid in purification. 
Rosetta 2 cells were transformed with the plasmid and over expressed overnight at 
18°C in 2XYT media with ampicillin (100 µg/mL) and chloramphenicol (50 µg/mL) used 
throughout and 250 µM IPTG used for induction. Cultures were spun at 3800 rpm 
(Sorvall H6000A rotor) for 30 min. Media was decanted and each pellet was 
resuspended in 50 mM sodium phosphate, pH 7.0, and 500 mM sodium chloride, 
pooled, and aliquoted in 1L pellets and stored at -80°C. 
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 Pellets were lysed by addition of lysozyme and HALT protease inhibitor (Roche) 
and rocked at 4°C. Pellet was brought up to 60 mL with Buffer A (50 mM sodium 
phosphate, pH 7.0, 500 mM sodium chloride, 5 mM β-mercaptoethanol) lysed by 3, 1 
minute bursts of sonication in a metal beaker on ice, with at least 30 seconds between 
to allow the lysate to cool. Lysate was spun at 18,000 rpm (SS34 rotor) for 30 minutes, 
and the decantate was filtered with 0.45 µm SFCA filters before loading onto the 
chromatography system. The filtered decantate was purified on a 4 mL TALON column 
(Clontech) pre-equilibrated in Buffer A, loaded and washed with 5 column volumes of 
Buffer A, and eluted with a 15 column volume gradient from Buffer A to Buffer B (50 mM 
sodium phosphate, pH 7.0, 500 mM sodium chloride, 5 mM β-mercaptoethanol, and 300 
mM imidazole). Protein containing fractions were pooled and cleaved overnight with ~1 
mg of TEV protease, while dialyzing at 4°C in a 10 kDa dialysis bag against 2L of 50 
mM Tris, pH 8.0, 35 mM sodium chloride, and 5 mM β-mercaptoethanol. After TEV 
cleavage the solution was concentrated and loaded onto gel filtration on a Superdex 
S200 16/60 (GE Healthcare) column in 100 mM Tris, pH 8.0, 50 mM potassium 
chloride. After gel filtration, protein containing fractions were pooled, concentrated, and 
flash frozen before storage at -80°C. 
 AdoMet synthesis was carried out in 10mL solutions of 100 mM Tris, pH 8.0, 50 
mM potassium chloride, 30 mM magnesium chloride, 15 mM adenosine triphosphate, 
10 mM methionine (13CH3-methyl methionine for the NMR studies), and 8% v/v β-
mercaptoethanol, and ~850 µg of MetK enzyme in a variation of a previous method.3 
Reactions were rocked at room temperature for 4-16 hours before loading reaction onto 
a Source 15S column. AdoMet was eluted using a 15 column volume gradient from 0-
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1M hydrochloric acid in milliQ water. AdoMet containing fractions pooled and brought to 
near dryness using a SpeedVac (Savant). Dried AdoMet stored at -20°C. 
Protein expression and purification 
The sequence for the E coli 897-1227 tryptic fragment that had been previously 
crystallized was amplified out of the supplied vector from Dr. Marcos Koutmos and 
inserted using BamHI and XhoI sites from the primers used to insert into a vector, pHT4 
(derived from pET15b, Novagen), with a Tobacco etch virus protease (TEV) cleavable 
N-terminal His-tag. The protein construct contained an N-terminal extension of Gly-Ser 
before lysine 897 upon cleavage by TEV protease. Glutamate to glutamine mutations at 
position 1097 or 1128 were generated from the wild type construct using Quikchange 
(Agilent) mutagenesis. Protein was overexpressed using Rosetta 2 (DE3) cells in 2XYT 
media in an IPTG-inducible system, induced at 18°C and grown overnight. Cells were 
pelleted and resuspended in 50 mM sodium phosphate, pH 7.0 with 500 mM sodium 
chloride, aliquoted and placed in the -80°C. Cell pellets were lysed by rocking at 4°C 
with lysozyme and HALT protease inhibitor (Roche) followed by sonication at ~90W for 
1 minute, 3-4 times, with at least 30 seconds between sonication to allow the lysate to 
cool. Lysate was centrifuged at 18,000 rpm (SS34 rotor) for 30 minutes. Soluble lysate 
was filtered with a 0.45 µm SFCA filter and loaded onto a 4 mL TALON column 
(Clontech) using a NGC chromatography system. The column was washed with 5 
column volumes of 50mM sodium phosphate, pH 7.0, 500mM sodium chloride, and 
5mM β-mercaptoethanol. The protein was eluted using a gradient with the same buffer 
containing 300mM imidazole. The fractions containing MetH and no major contaminants 
were pooled and cleaved with ~1 mg TEV protease overnight in a 10 kDa dialysis bag, 
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dialyzing against 2 L of 20 mM sodium phosphate, pH 8.0, 35 mM sodium chloride and 
5mM β-mercaptoethanol. After cleavage, solution was passed over a small TALON 
column to remove uncleaved MetH and the TEV protease. The solution was 
concentrated to 3-6 mg/mL, brought to 5% v/v glycerol and incubated with activated 
charcoal (Sigma) at a ratio of 2:1 mg/mg charcoal:protein and rocked at room 
temperature for at least 20 minutes to remove bound AdoMet. The solution was 
centrifuged and filter to remove charcoal, and the protein was further concentrated and 
loaded onto a Superdex S200 16/60 column in 20 mM sodium phosphate, pH 8.0, 100 
mM sodium chloride. Protein containing fractions were pooled, concentrated, flash 
frozen, and stored at -80°C until use. 
Crystallization 
Protein was crystallized by hanging drop vapor diffusion with a reservoir containing 27-
32% PEG 6000, 60-100 mM Tris pH 7.2-7.5, with 300 mM magnesium acetate. The 
protein solution contained 15 mg/mL of MetH, 3 mM of AdoMet or Sinefungin, and 10 
mM Tris buffer, pH 7.4, with the remaining volume made up by the addition of 10 mM 
EDTA. The AdoHcy was similar, with 5 mM AdoHcy and 20 mM Tris buffer, pH 7.4, with 
the addition of 20 mM EDTA, with twice the EDTA concentration being added due to the 
limited solubility of AdoHcy, resulting in the ligand stock taking a larger portion of the 
protein solution volume relative to AdoMet, leaving less volume for the addition of the 
EDTA. Crystals were cryoprotected in 34% PEG 6000, 100 mM Tris pH 7.25, 300 mM 
magnesium acetate and flash frozen in liquid nitrogen.  
Data were collected on the MarMosaic 300 detector of the LS-CAT 21-ID-G beamline at 
the Advanced Photon Source of Argonne National Laboratory.  HKL2000 was used to 
38 
 
process and scale the datasets.141 Molecular replacement was performed using 
Phaser142, with 1MSK72 stripped of ligands, waters, and converted to poly-alanine used 
as the search model for the sinefungin- and AdoMet-bound structures, and mostly 
refined AdoMet-bound structure stripped of ligands and waters for the search model for 
the AdoHcy-bound structure. Coot143 was used for model building, and Phenix144 was 
used for refinement. Images for structural figures were generated using the PyMOL 
Molecular Graphics System, Schrödinger, LLC. Electrostatic surface was generated 
using the APBS plugin for PyMOL.145 
QM calculations 
Quantum mechanical binding energies were obtained by subtraction of the energies of 
the optimized monomers from the complex energy calculated using M06-2X/6-31+G**. 
The counterpoise correction method was used to correct for basis set superposition 
error. Positions of hydrogen atoms were optimized, while other atoms were either frozen 
in the crystallographic positions or allowed to optimize, as described in the text. 
ITC 
Isothermal titration calorimetry was performed in a VP-ITC calorimeter (Malvern 
instruments) for wild type MetH, and an Auto ITC-200 (Malvern instruments) for the 
mutant MetH proteins, with 20 mM sodium phosphate pH 8.0, 100 mM sodium chloride 
used as the buffer. Wild type AdoMet and sinefungin titrations were performed with 60 
µM protein and 600 µM ligand, and AdoHcy titrations were performed with ~200 µM 
protein and 2.2 mM ligand. E1097Q and E1128Q mutant AdoMet titrations were 
performed with 840-870 µM protein and 9.6 mM ligand, sinefungin titrations were 
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performed with 830-910 µM protein and 16.2 mM ligand, and AdoHcy titrations were 
performed with 810-940 µM protein and 10.1-10.7 mM ligand. Titrations of the E1097Q 
and E1128Q mutants with sinefungin used sinefungin dissolved 20 mM sodium 
phosphate pH 8.0, 100 mM sodium chloride and titrated back to pH 8.0 using 210 mM 
hydrochloric acid in 20 mM sodium phosphate pH 8.0, 100 mM sodium chloride, to keep 
the ionic strength of the buffer the same. Each titration was performed once, and the 
curves were fitted using the Origin graphing software provided with the instrument.
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Appendix: ITC titrations of MetH 
Figure A.1A: ITC titration of WT MetH with AdoMet 
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Figure A.1B: ITC titration of WT MetH with AdoHcy 
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Figure A.1C: ITC titration of WT MetH with Sinefungin 
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Figure A.1D: ITC titration of MetH E1097Q with AdoMet 
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Figure A.1E: ITC titration of MetH E1097Q with AdoHcy 
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Figure A.1F: ITC titration of MetH E1097Q with Sinefungin 
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Figure A.1G: ITC titration of MetH E1128Q with AdoMet 
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Figure A.1H: ITC titration of MetH E1128Q with AdoHcy 
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Figure A.1I: ITC titration of MetH E1128Q with Sinefungin 
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Figure A.1: Isothermal titrations and fitted isotherms of various ligands with WT MetH 
and the E1097Q and E1128Q mutants. 
 WT MetH with AdoMet (A), AdoHcy (B), and Sinefungin (C). MetH E1097Q with 
AdoMet (D), AdoHcy (E), and Sinefungin (F). MetH E1128Q with AdoMet (G), AdoHcy 
(H), and Sinefungin (I). 
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Chapter 3: 
Sulfur−Oxygen Chalcogen Bonding Mediates AdoMet Recognition in 
the Lysine Methyltransferase SET7/9 
Robert J. Fick, Grace M. Kroner, Binod Nepal, Roberta Magnani, Scott Horowitz, 
Robert L. Houtz, Steve Scheiner, and Raymond C. Trievel 
 
3.1 Introduction 
SET7/9 belongs to the SET domain class of lysine methyltransferases.79  SET7/9 has 
been intensely studied by the Trievel laboratory, both in its ability to bind and catalyze 
methylation on peptide substrates146, 147 and in the role of carbon-oxygen (CH•••O) 
hydrogen bonding in binding of S-adenosyl-L-methionine (AdoMet) and conducting 
catalysis of the methyl transfer reaction.47, 83, 84  As part of the studies of CH•••O 
hydrogen bonding in SET7/9, CH•••O hydrogen bonding to the AdoMet methyl group 
was surveyed in high resolution (< 2.0 Å) AdoMet-bound methyltransferase structures. 
Reproduced with permission from 
ACS Chem. Biol., 2016, 11 (3), pp 748–754 
DOI: 10.1021/acschembio.5b00852 
Publication Date (Web): December 29, 2015 
Copyright © 2015 American Chemical Society 
 
RJF performed the binding studies and differential scanning calorimetry and finished 
structure refinement. GMK crystallized the protein and performed initial structure 
refinement. BN and SS performed quantum mechanical calculations. SH made the 
construct and provided discussion on the manuscript. RM performed the radiometric 
assays. RJF and RCT prepared the manuscript. 
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This survey established that CH•••O hydrogen bonding to the AdoMet methyl group is 
not just a feature of SET7/9, but appears to be a universally conserved feature of all 
AdoMet-dependent methyltransferases.47 Another interaction seen within the active site 
of SET7/9 is an apparent S•••O chalcogen bond, with a distance of 3.0 Å between an 
asparagine sidechain oxygen and the sulfonium sulfur of AdoMet. This distance is much 
shorter than 3.3 Å of the combined van der Waals radii of these two atoms.32 A 
chalcogen bond is a σ-antibonding interaction, similar to a halogen bond,50 in which a 
lone pair is able to be donated into an antibonding orbital of a chalcogen atom 
(elements of column 16 of the periodic table, including O, S, Se, etc.). There is evidence 
for these interactions in biological systems, with the relative enrichment of oxygen in 
contacts closer than van der Waals radii near sulfurs in methionine and cystine systems 
(C-S-C and C-S-S) within proteins. 53-55 The chalcogen bond also presents another 
possible interaction in which methyltransferases can preferentially bind AdoMet, as the 
interaction energy with a sulfonium is much greater than with the thioether system.45 
3.2 Structural Study 
The SET7/9 N265A mutant was produced to remove the chalcogen bond with minimal 
disruption to the enzyme. Before biochemical characterization of the mutant enzyme, 
the structure was determined to verify active site integrity. SET7/9 N265A crystal trials 
were set up with AdoMet and a known TAF10 substrate peptide, resulting in methyl 
group transfer from AdoMet to the lysine of the TAF10 and the formation of the product 
complex of SET7/9 N265A with S-adenosylhomocysteine (AdoHcy) and the TAF10 
K189me1 peptide. The crystal diffracted to 1.55 Å (see Table 3.1), and was highly 
similar to the wild type enzyme with a 0.19 Å Cα RMSD for aligned atoms. The active 
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site showed that the loss of the chalcogen bond and other interactions formed by the 
asparagine sidechain caused no major change in the active site conformation or 
rearrangement of active site waters to occupy the location of the larger side chain 
(Figure 3.1). To further verify enzyme integrity, enzyme melting temperature was 
determined by differential scanning calorimetry (DSC, Figure 3.2). This revealed a minor 
decrease in melting temperature (44.3°C) relative to that of the wild type enzyme 
(46.6°C), owing in part to the loss of the hydrogen bond between the asparagine 
sidechain and the carbonyl oxygen of valine 277, among other interactions.  
 
Table 3.1 Crystallographic and refinement statistics for SET7/9 N265A. 
      SET7/9 N265A•TAF10 K189me1•AdoHcy 
PDB Code   5EG2 
Data Collection   
Wavelength (Å)  0.97903 
Space  group  P3221 
Cell dimensions   
   a, b, c (Å)  83.20, 83.20, 95.86 
   α, β, γ (°)  90, 90, 120 
Resolution (Å)  39.91  - 1.55 (1.59  - 1.55) 
Rmerge (%)  6.8 (90.4) 
<I/σI>   19.49 (3.66) 
Completeness  99.6  (100) 
Redundancy  10.9 (10.7)     
Refinement   
Resolution  1.55 
No. of Reflections  56156 
Rwork/Rfree   0.15/0.17 
No. of Atoms  2282 
   Protein   1939 
   Ligand/ion  27 
   Water   316 
B-factors   29.5 
   Protein   27.6 
   Ligand/ion  32.2 
   Water   41.3 
R.M.S. Deviations   
   Bond lengths (Å)  0.009 
   Bond angles (°)  1.18 
MolProbity Score   
   Percentile  98% 
    Resolution Range (Å) 1.55 ± 0.25 
Ramachandran   
   Favored (%)  96.8 
   Allowed (%)  3.2 
Outliers (%)   0 
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Figure 3.1: The chalcogen bond in SET7/9 and the SET7/9 N265A active site. 
The active site of SET7/9 WT•AdoMet•TAF10 K189A (PDB ID: 4J83)47 showing the 
chalcogen bond to asparagine 265 (A). CH•••O hydrogen bonding in the SET7/9 active 
site is shown as orange dashes. The chalcogen bond between the asparagine 
sidechain carbonyl and the AdoMet sulfur is shown as purple dashes. Classical 
hydrogen bonding network between an active site valine backbone carbonyl, the 
asparagine sidechain, an active site water, and the AdoMet carboxylate shown as cyan 
dashes. Active site of the SET7/9 N265A•AdoHcy•TAF10 K189me1 complex with the 
site of the mutation shown in slate blue (B). Simulated annealing omit map (FO - FC) 
contoured at 2.0 σ (C). The map is displayed for AdoHcy, TAF10 K189me1, alanine 
265, valine 277, and the water that engaged in hydrogen bonding shown in (A). No 
water was seen in place of the asparagine sidechain. 
 
Figure 3.2: Differential Scanning Calorimetry of the SET7/9 N265A mutant. 
Differential Scanning Calorimetry (DSC) was performed to confirm mutant stability. The 
melting temperature of 44.3°C is slightly lower than the wildtype value of 46.6°C.47 
 
3.3 Biochemical and Quantum Mechanical Characterization 
 Binding of the mutant enzyme to the TAF10 peptide was measured to confirm a 
defect was not present that may complicate kinetic analysis (Figure 3.3). The binding 
constant was within 1.4-fold of the wild type value (Table 3.2). Binding of the enzyme to 
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AdoMet measured by isothermal titration calorimetry (ITC) showed an 8-fold loss in 
binding relative to wild type (Figure 3.4). The binding to AdoHcy was measured by an 
intrinsic tryptophan fluorescence assay and was found to be only disrupted around 2-
fold. This represents a 4-fold loss in substrate/product discrimination. The loss of affinity 
for AdoMet is also seen in the radiometric activity assay run with SET7/9 N265A, with a 
7-fold increase in the KM of AdoMet and a 7-fold decrease in the catalytic rate.  
Quantum mechanics was used to probe the binding energies of the interactions 
by determining the energies of complex formation for minimal model systems (Figure 
3.5). The minimal models included N-methylacetamide (NMA) in place of the backbones 
of valine 277 and histidine 293. The sidechain of tyrosine 335 was modeled as a 4-
methylphenol group, asparagine 265 was modeled as a propanamide, and the alanine 
mutation was modeled as an ethane. The water that hydrogen bonds to the asparagine 
sidechain was also modeled. AdoMet was modeled as diethylmethyl sulfonium, and 
AdoHcy was modeled as diethyl thioether. Select model atoms were frozen in their 
crystallographic positions to prevent deviation of the model during energy minimization. 
The loss of selectivity in binding AdoMet over AdoHcy is also borne out in the quantum 
mechanical results. The difference between the AdoMet and AdoHcy binding energies 
is greater in wild type than in the N265A mutant. The loss of binding energy upon 
mutation relative to wild type in the AdoMet-like complex is 21 kcal/mol, while the loss 
for the AdoHcy complex is only 10 kcal/mol, recapitulating the effect seen in charged vs 
uncharged chalcogen systems.45 The loss of energy upon mutation in the quantum 
mechanical systems cannot be purely ascribed to the loss of a chalcogen bond, as the 
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AdoMet also forms a possible CH•••O hydrogen bond to the asparagine side chain 
(Figure 3.7B).  
  
Figure 3.3: Isothermal Titration Calorimetry of SET7/9 N265A with TAF10 peptide 
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Figure 3.4: Biochemical Characterization of the SET7/9 N265A mutant. 
Isothermal Titration Calorimetry of SET7/9 N265A with AdoMet (A). Intrinsic tryptophan 
fluorescence assay of AdoHcy binding to SET7/9 N265A (B). Radiometric assay of 
SET7/9 N265A with a fitted Michaelis-Menten curve. 
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Table 3.2: Biochemical and quantum mechanical values for SET7/9 wild type and 
N265A. 
          KD (μM)     
    WT   N265A 
AdoMet 
 
0.053 ± 0.003a 
 
0.41 ± 0.03d 
AdoHcy 
 
134 ± 36b 
 
301 ± 18e 
TAF10 
 
4.9 ± 0.1c 
 
3.7 ± 0.3d 
Sinefungin 
 
0.33 ± 0.02a 
 
7.46 ± 0.07d 
        Kinetic Parameters   
                  
kcat (min-1) 
 
29.6 ± 0.9b 
 
4.16 ± 0.14 
AdoMet KM (μM) 
 
2.5 ± 0.3b 
 
18.3 ± 2.9 
kcat/KM (μM-1 min-1) 
 
12 ± 1.5b 
 
0.227 ± 0.037 
    QM binding energy (kcal mol-1) 
Complex energy       WT   N265A   ΔE 
MeS+(Et)2 complex 
energy 
  
-56.48 
 
-35.43 
 
-21.05 
S(Et)2 complex 
energy 
   
-19.61 
 
-9.72 
 
-9.89 
3-NH3+-pentane complex energy 
 
-72.74 
 
-45.22 
 
-27.52 
3-NH2-pentane complex energy 
 
-29.54 
 
-15.86 
 
-13.68 
Wild type values were reproduced from a: Horowitz et al.83 b: Horowitz et al.47 and c: 
Del Rizzo et al.146 Binding values were obtained by ITC (d), and intrinsic tryptophan 
fluorescence assay (e). QM binding energies were obtained by subtraction of the 
energies of the optimized monomers from the complex energy calculated using M06-
2X/6-31+G**. 
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Figure 3.5: Representative system of the quantum mechanical models. 
Model representative of AdoMet bound to the wild type SET7/9 active site. Distances 
and residues are labeled, and frozen atoms are marked with an asterisk. 
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Figure 3.6: Isothermal Titration Calorimetry of SET7/9 N265A with sinefungin 
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Figure 3.7: Binding of sinefungin to SET7/9. 
Key interactions of sinefungin binding to SET7/9 (from 3CBP)85 shown, with 
orange dashes for CH•••O hydrogen bonds, and cyan dashes for classical hydrogen 
bonds (A). Overlay of AdoMet (from 4J83) and sinefungin bound to asparagine 265 (B). 
Active site residues from the AdoMet structure shown as light gray and the residues 
from the sinefungin structure shown in dark gray. The chalcogen bond is shown as 
purple dashes.  
 
The AdoMet analog sinefungin, in which the S+-CH3 is substituted by CH-NH3+, 
(Figure 3.7A) presented the opportunity to study the binding of a ligand without the 
ability to form a chalcogen bond. The affinity of the mutant for sinefungin was more 
dramatically affected than that of AdoMet, with a ~23-fold loss in binding relative to 
sinefungin binding to wild type SET7/9. The explanation for this phenomenon is that 
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sinefungin binds to the asparagine sidechain with both a CH•••O hydrogen bond and a 
NH•••O hydrogen bond, thereby replacing the S•••O chalcogen bond and CH•••O 
hydrogen bond, respectively (Figure 3.7). The crystal structure of SET7/9 bound to 
sinefungin even shows movement of the asparagine 265 sidechain to better form the 
NH•••O hydrogen bond to the amine of sinefungin. Quantum mechanical models similar 
to what had been used for the AdoMet and AdoHcy binding energies were used for the 
calculation of sinefungin binding energies. Because the protonation state of the amine 
group of sinefungin was not known, the models included either 3-aminopentane in the 
amine ((Et)2CHNH2) or ammonium ((Et)2CHNH3+) state. The ammonium model system 
showed a much greater binding energy (Table 3.2) than did the amine models system, 
consistent with the effects of charge on hydrogen bonding.44 The large difference seen 
in the ammonium system is consistent with the dramatic loss in binding to the mutant. 
The binding energy of the ammonium system is greater than AdoMet in both the 
wildtype and mutant models, indicating a possible mix of ammonium and amine states 
within the active site. 
3.4 Discussion 
 The importance of the S•••O chalcogen bond within the active site of SET7/9 in 
binding and catalysis leads to the question of the general importance of S•••O 
chalcogen bonding in methyltransferases. Considering the conservation of CH•••O 
hydrogen bonding to the AdoMet methyl across methyltransferase classes, examination 
of the original set of structures used for the survey of AdoMet methyl CH•••O hydrogen 
bonding was undertaken. Additionally, further structures were surveyed to increase the 
diversity of classes. The results of this survey (Figure 3.8) indicate that chalcogen 
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bonding to the AdoMet sulfonium is a much more limited interaction within 
methyltransferase active sites, with only the Rossmann-like fold, SPOUT, and SET 
domain classes represented. 
  
Figure 3.8: Chalcogen bonding in AdoMet-dependent methyltransferases. 
Chalcogen bonds shown are < 3.3 Å and > 150°, where the angle is defined as the 
O•••S-C for the S-C bond anti the σ antibonding orbital. The classes represented above 
are the Rossmann-like fold (Class I: 3PFG, 1JG4, 1ZQ9), SPOUT (Class IV: 1UAK), 
and SET domain (Class V: 3RQ4, 4J83).96, 148-150 
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The interaction does not even represent a conserved feature within those classes. 
Though chalcogen bonding is not a conserved feature, it still has characteristics seen in 
CH•••O hydrogen bonding that make them important in methyltransferases. Both 
CH•••O hydrogen bonding and S•••O chalcogen bonding are charge-dependent in the 
strength of their interaction, favoring the sulfonium of the substrate AdoMet over the 
thioether of the product AdoHcy. The loss of the chalcogen bond also showed catalytic 
defects, with the stabilization of the SN2 reaction by sulfur binding as the possible 
cause. 
The ability of sinefungin to bind to the residue that is responsible for chalcogen 
bonding represents an opportunity for inhibitors to target such interactions. This is 
possible even if the inhibitors are lacking an atom to chalcogen bond at that position, as 
is the case with sinefungin. In this case, the uniqueness of chalcogen bonding presents 
the opportunity for selectivity in binding a methyltransferase target, as the interaction is 
only in select methyltransferases and not always in the same position, bonding anti to 
the ribosyl methylene in two of the methyltransferases and anti to the methionyl 
methylene in the four others surveyed. 
3.5 Materials and Methods 
Protein purification 
The N265A SET7/9 expression vector was produced using Quikchange  site-directed 
mutagenesis (Agilent) on the WT SET7/9 110-366 pHIS2 construct.146, 147 The plasmid 
was transformed into Rosetta2 (DE3) cells and overexpressed in a manner similar to 
what has been previously described.81  
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The protein was purified as previously described, with the exception of adding a 
charcoal treatment post-TEV cleavage to remove AdoMet cofactor instead of using a 
denaturation and refolding step. The charcoal treatment involved concentrating the 
protein and adding 5% v/v glycerol, with a final protein concentration of ~5 mg/mL. 
Activated charcoal (Sigma) was added at a ratio of 1.5 to 2 mg per mg of protein, and 
the solution was rocked at room temperature for 10-20 minutes. The solution was then 
centrifuged to pellet the charcoal, the solution was decanted by serological pipette, 
filtered by 0.45 um PTFE filter, and further concentrated for loading onto the gel filtration 
column. 
For the tryptophan fluorescence studies the protein was purified by refolding as 
previously described.83 
Structure refinement 
Model building using Coot143 and refinement using Phenix144 was continued for the 
partially refined structure obtained from GMK. Images for structural figures were 
generated using the PyMOL Molecular Graphics System, Schrödinger, LLC. 
Tryptophan fluorescence binding study 
The intrinsic tryptophan fluorescence assay makes use of the quenching of an internal 
tryptophan residue upon AdoHcy binding, as the adenine ring stacks with the tryptophan 
ring. The enzyme was at 1.75 µM as with previous experiments in the lab.47 The top 
concentration of AdoHcy (Sigma) used was 9.26 mM, with ten additional points from 2-
fold dilutions of the top concentration and also a zero point. AdoHcy inherent 
fluorescence was background subtracted by using AdoHcy at the same concentration in 
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buffer as a reference. The maximal fluorescence value for the tryptophan residue was 
determined by fitting a gaussian to a fluorescence scan of 320-390 nm with excitation at 
280 nm. The maximal values as determined by the gaussian fit were used to fit a 
hyperbola, from which the KD was determined. The AdoHcy dilution series with protein 
was run in triplicate on one plate. The R-squared of the fit was 0.9971. Prism 
(GraphPad) was used as the fitting software. 
QM calculations 
Quantum mechanical binding energies were obtained by subtraction of the energies of 
the optimized monomers from the complex energy calculated using M06-2X/6-31+G**. 
The counterpoise correction method was used to correct for basis set superposition 
error. Positions of hydrogen atoms were optimized, while other atoms were either frozen 
in the crystallographic positions or allowed to optimize, as seen in the minimal model 
system.151 
Isothermal titration calorimetry 
The AdoMet and TAF10 peptide KD’s were determined using a Microcal VP-ITC 
(Malvern instruments) with previously described conditions.146 The AdoMet titration 
contained 6.66 µM protein in the cell and 84.8 µM AdoMet (Sigma, purified using the 
Source 15S, see Chapter 2.6 for details) in the syringe. The TAF10 titration was 
performed as previously described.146 Curves were fitted using the Origin graphing 
software provided with the instrument.
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Chapter 4: 
Functions of CH•••O Hydrogen Bonding in the Rossmann-like fold 
Methyltransferase TylM1 
Robert J. Fick, Brandon McDole, James B. Thoden, Hazel M. Holden, Steve Scheiner, 
Raymond C. Trievel 
 
4.1 Introduction 
TylM1 is a Rossmann-like fold methyltransferase that uses S-adenosyl-L-
methionine (AdoMet) to N,N dimethylate a dTDP-loaded deoxyamino sugar.152 The 
methylation at this position is the final step in the biosynthesis of mycaminose. 
Mycaminose is attached to a macrolide core along with another sugar, and the addition 
of a third sugar attached to different position on the macrolide forms the antibiotic, 
tylosin.153 TylM1 also poses as an ideal model system representing the Rossmann-like 
fold methyltransferases, as the enzyme has been biochemically153 and structurally 
characterized,96 and contains residues within the active site that can be mutated to 
remove CH•••O hydrogen bonds to AdoMet. The Rossmann-like fold 
methyltransferases, also called Class I because they were the first methyltransferase 
RJF purified the protein and AdoMet, performed the biochemical assays, and refined 
the structures. RJF and BM crystallized the proteins. JBT and HMH provided the 
construct, dTDP-phenol inhibitor, and dTDP-Quip3N substrate. SS performed the 
quantum mechanical calculations. 
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class to be structurally characterized,62 remain the largest and most diverse class of 
methyltransferases.59, 61 This class has been a particular point of study with respect to 
the mechanism by which AdoMet-dependent methyltransferases conduct catalysis, 
specifically in the enzyme catechol O-Methyltransferase (COMT).4, 99, 100, 111, 114 
The purpose of this study was to examine the effects of carbon-oxygen (CH•••O) 
hydrogen bonding in the context of a Rossmann-like fold methyltransferase. TylM1 was 
identified in a survey of high-resolution (<2.0 Å) AdoMet-bound structures in the PDB 
that examined CH•••O hydrogen bonding to the AdoMet methyl group.47 This survey 
found that CH•••O hydrogen bonding was a conserved feature of AdoMet-dependent 
methyltransferases. The functions of these bonds were explored in the SET domain 
methyltransferase SET7/9, identifying binding and catalytic defects upon mutation of 
tyrosine 335, a key CH•••O hydrogen bonding residue to the AdoMet methyl group.47, 84 
The residues that can be mutated in TylM1 expand on these previous studies, as 
tyrosine 14 CH•••O hydrogen bonds to the AdoMet methyl similar to tyrosine 335 
studied in SET7/9, but serine 120 bonds to the AdoMet methylene groups. 
4.2 Structural Study 
TylM1 wild type and mutant (Y14F, S120A, and Y14F S120A) enzymes were 
crystallized to determine any structural abnormalities upon mutation of the active site. A 
noncanonical amino acid, para-aminophenylalanine (pAF), was also used, similar to 
previous studies,84 yielding the Y14pAF mutant. The substitution of pAF for tyrosine 
effectively replaces the hydroxyl of the tyrosine side chain with an amine group. The 
wild type enzyme diffracted to high resolution, 1.05 Å, and was very similar to the 
previously solved wild type structure, PDB ID: 3PFG, with a RMSD for the aligned Cα 
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atoms of 0.10 Å. The mutant enzymes were less similar to the wild type structures, 
crystallizing in different space groups than the previously reported structures, and 
though they were crystallized in the presence of AdoMet, the product S-
adenosylhomocysteine (AdoHcy) was found within the mutant active sites (Table 4.1).96, 
154 The S120A, Y14pAF, and Y14F S120A mutants were collected to 1.3 – 1.4 Å  
resolution and were in the I222 space group, with the single mutants having a RMSD of 
0.15-0.17 Å for the Cα atoms aligned to the double mutant, and an RMSD of 0.085 Å for 
the Cα atoms aligned between the two single mutants. The Y14F mutation resulted in 
twinned crystals, with a dataset collected after around 100 crystals had been screened. 
The Y14F mutant also exhibited the lowest resolution of the TylM1 datasets collected 
with a resolution of 1.78 Å. There were four nonequivalent monomers within the 
asymmetric unit which exhibit RMSD’s of 0.27-0.46 Å for Cα atoms aligned to one 
another. Despite the differences between the TylM1 wild type and mutant structures, the 
active sites were largely similar. There were variations of the position of the phenol 
group of the dTDP-phenol inhibitor (Figure 4.1), but the AdoMet/AdoHcy and residue 14 
superimpose. The histidine 123 shows variation in position in both phenylalanine 
mutations at the 14 site. This indicates a disruption of binding from the normal pattern 
within the active site. Histidine 123 has been mutated in previous studies, and both 
asparagine and alanine mutations at that position show binding and catalytic defects.96 
A Michaelis complex was modeled, using the AdoMet from the wild-type structure of 
these studies and the nucleophile substrate from 3PFH. The tyrosine at position 14 
engages in a hydrogen bond to histidine 123, a CH•••O hydrogen bond to the AdoMet 
methyl group, and a second classical hydrogen bond to the methyl acceptor substrate 
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with one of the sugar hydroxyl groups.  The importance of tyrosine 14 at this position is 
seen in the apparent disparity between the calculated binding energies and the 
biochemical characterizations of these enzymes. 
 
Table 4.1: Crystallographic and refinement statistics of TylM1 WT and mutants. 
TylM1 WT• 
AdoMet• dTDP-
phenol
TylM1 Y14F• 
AdoHcy• dTDP-
phenol
TylM1 Y14paF• 
AdoHcy• dTDP-
phenol
TylM1 S120A• 
AdoHcy• dTDP-
phenol
TylM1 Y14F 
S120A• AdoMet• 
dTDP-phenol
Data Collection
Wavelength (Å) 0.97903 0.97903 0.97903 0.97903 0.97903
Space  group C2 P21 I222 I222 I222
Cell dimensions
   a, b , c (Å)
88.19 41.53 
85.81
73.90 92.35 
80.56
64.56 91.57 
93.39
64.52 91.27 
93.63
64.57 90.89 
93.25
   α, β, γ (°) 90 120.08 90 90 106.44 90 90 90 90  90 90 90  90 90 90
Resolution (Å) 30.02-1.05 
(1.07-1.05)
35.44-1.78 
(1.82-1.78)
34.97-1.40 
(1.43-1.40)
32.68  - 1.37 
(1.40  - 1.37)
34.9  - 1.33 
(1.36  - 1.33)
Rmerge (%) 6 (n/a) 6.4 (30.9) 3.8 (57.5) 4.9 (42.3) 4.0 (95.8)
CC1/2 (0.417) (0.950) (0.733) (0.838) (0.800)
<I> /<σI > 23.72 (1.05) 44.26 (4.13) 56.87 (1.71) 44.01 (2.12) 63.94 (2.50)
Completeness 99.9 (99.7) 97.5 (80.7) 98.1 (76.0) 97.9 (77.3) 96.9 (94.8)
Redundancy 4.7 (3.0) 7.0 (4.6) 13.1 (3.4) 12.6 (3.2) 14.9 (13.2)
Refinement
Resolution 1.05 1.78 1.40 1.37 1.33
No. of Reflections 125133 96411 53914 57235 61443
R work/Rfree 0.15/0.16 0.18/0.21 0.15/0.17 0.15/0.18 0.16/0.19
No. of Atoms 2265 8181 2125 2117 2100
   Protein 1852 7167 1806 1835 1831
   Ligand/ion 58 228 57 57 57
   Water 351 786 260 224 212
B-factors 22.06 28.31 24.1 20.99 23.26
   Protein 18.99 27.34 21.84 19.62 22.18
   Ligand/ion 13.67 30.16 28.49 19.51 19.96
   Water 39.68 36.62 38.64 32.62 33.5
R.M.S. Deviations
   Bond lengths (Å) 0.005 0.007 0.014 0.015 0.012
   Bond angles (°) 1.2 1.15 1.49 1.61 1.47
Ramachandran
   Favored (%) 99.16 99.05 98.71 98.31 98.72
   Allowed (%) 0.84 0.84 1.29 1.69 1.28
Outliers (%) 0 0.11 0 0 0
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Figure 4.1: TylM1 wild-type and mutant active sites. 
TylM1 wild-type (A), Y14F (B), Y14pAF (C), S120A (D), and Y14F S120A double mutant 
(E) shown. The relative positions of the active site residues and ligands shown from the 
superimposition of the Cα atoms of the protein chains (F).   
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Figure 4.2: Modeled Michaelis complex of TylM1. 
The wild-type structure modeled in complex with the substrate dTDP-Quip3N (PDB ID: 
3PFH) by alignment of the Cα atoms of both structures. Active site residues and 
AdoHcy from 3PFH shown in dark gray, indicating the good alignment within the active 
site. Select classical hydrogen bonds shown as cyan dashes, CH•••O hydrogen bonds 
formed by tyrosine 14 and serine 120 shown as orange dashes, alignment of the 
AdoMet methyl with the nitrogen nucleophile shown in black, and a possible clash within 
the model shown in hot pink. The possible clash, coupled with the somewhat acute 
angle for the reaction indicate that there may be some rearrangement upon binding of 
both substrates. 
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4.3 Quantum Mechanical Study 
Quantum mechanical studies of minimal models (see Figure 4.3 for an example) 
were undertaken to determine the relative energy perturbations in active sites 
corresponding to the mutations made. Binding could not be characterized by isothermal 
titration calorimetry, so the binding energies of modeled active sites were used to 
access disruption caused by specific mutations. The position of protonation of histidine 
123 could not be determined, and thus was modeled in both positions. The serine 120 
to alanine mutation shows a loss of binding energy to AdoMet greater than that to 
AdoHcy; therefore, this results in a smaller difference of energy between the two 
complexes and a theoretical loss of the ability to discriminate substrate from product. 
This is evidence that the two CH•••O hydrogen bonds that serine 120 can form with the 
AdoMet methylenes (see Figure 4.2) can aid in enzyme selectivity toward its substrate. 
The Y14F loses binding energy about equally for AdoMet and AdoHcy when Nε2 is 
protonated leaving the difference in energy between the two complexes about the 
same. When Nδ1 is protonated, there is a much larger loss in binding energy for both 
ligands, but this position still has a greater energy difference between the ligands, 
indicating the tyrosine 14 is less discriminating in ligand preference than the serine 120. 
The Y14pAF shows the least defective binding energies of the mutants, with the 
possible compensation for loss of the CH•••O bond by the formation of the similar 
CH•••N hydrogen bond, which has been previously observed in calculations using this 
amino acid.84 The Y14F S120A double mutant has the largest disruption of binding 
energy to both ligands, with the loss in binding energy similar to the combined loss in 
energies of the independent single mutations. 
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Figure 4.3: Optimized geometry of a representative TylM1 minimal active site. 
Active site residues modeled as minimal functional groups to probe binding energies of 
AdoMet-like or AdoHcy-like molecules. In this model the Nδ1 of histidine 123 is modeled 
as protonated.  
 
Table 4.2: Quantum mechanical binding energies of TylM1 model complexes 
 
4.4 Biochemical Study 
To study the effects of CH•••O hydrogen bonding on catalysis in a class I 
methyltransferase, a continuous, coupled fluorescent assay was used. Saturating levels 
of the dTDP-Quip3N substrate were used and kcat and the KM for AdoMet were 
determined. The wild type TylM1 enzyme had a kcat value of 4.74 min-1 at pH 7.5, and a 
KM of 27.3 µM for AdoMet. The catalytic value is slightly slower at pH 7.5 than the 
observed value of ~10 min-1 at pH 8.0,96 as the more basic pH should increase the 
deprotonation of the amine nucleophile. The serine 120 to alanine mutation showed 
roughly a two-fold loss in both kcat and KM, with values of 2.9 min-1 and 59.3 µM. Both 
TylM1 Complex MeS+(Et)2 S(Et)2 [MeS
+(Et)2 - S(Et)2] MeS+(Et)2 S(Et)2 [MeS
+(Et)2 - S(Et)2]
WT -51.69 -25.56 -26.13 -65.49 -27.27 -38.22
S120A -42.41 -21.53 -20.88 -56.74 -23.45 -33.29
Y14F -46.74 -21.09 -25.65 -56.04 -21.74 -34.3
Y14paF -50.81 -24.23 -26.58 -62.2 -24.94 -37.26
Y14F/S120A -37.34 -16.12 -21.22 -46.83 -17.39 -29.44
H123 Nε2 protonated H123 Nδ1 protonated
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the Y14F single mutant and Y14F S120A double mutant appeared catalytically inactive 
when used at the concentration and time of reaction for the WT and S120A enzymes 
(Figure 4.4). Though the binding energy loss in the computation study of minimal active 
sites showed little loss of energy upon mutation of tyrosine 14 to phenylalanine, the 
complete loss of catalytic activity in both of the enzymes containing the mutation at this 
site seems to indicate that the loss of binding both substrates in a coordinated manner 
may disrupt formation of a catalytically productive complex.
 
Figure 4.4: Biochemical characterization of TylM1 wild type and mutant enzymes. 
Wild type TylM1 (green) and S120A (orange) show activity by the continuous assay, 
with fit parameters labeled to the right of the curves. The error on the values is the 
standard error. The Y14F and Y14F S120A mutants are not labeled but are shown in 
yellow and red along the baseline.  
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4.5 Discussion 
 TylM1 is a Rossmann-like fold methyltransferase, and the ease of crystallization 
and use in steady state assays make it an optimal enzyme to determine the effects of 
CH•••O hydrogen bonding in this class of methyltransferases. The serine 120 to alanine 
mutation shows subtle defects in AdoMet affinity and catalysis. This demonstrates the 
ability of methylene CH•••O interactions to influence the SN2 reaction. The ability to 
kinetically characterize the effects of phenylalanine mutations at residue 14 within 
TylM1 was precluded by the lack of catalytic activity, possibly owing to a lack of 
alignment of AdoMet with the second substrate dTDP-Quip3N, which also hydrogen 
bonds to this residue. Though the alignment of the AdoMet methyl axis and nitrogen 
nucleophile could be closer to 180° in the modeled Michaelis complex, indicating some 
active site rearrangement may be necessary, the loss of the bifurcated interaction seen 
with the tyrosine 14 hydroxyl group may allow more conformational freedom for the 
sugar moiety, similar to the positional freedom seen with the phenol ring of the inhibitor. 
The coupled assay will be used to determine the kinetic parameters of the Y14pAF 
mutant, which may restore the ability to hydrogen bond with dTDP-Quip3N, but the 
analysis will be complicated by the ability to form CH•••N hydrogen bonds, as seen in 
the minimal perturbation of binding energy in the quantum mechanical calculations. 
Further QM calculations will be used to probe the energies of the methyl transfer 
reaction with model systems in the presence and absence of the tyrosine 14 sidechain, 
exploring whether the catalytic defect is caused by mis-alignment or a raising of the SN2 
energetic barrier.  
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4.6 Materials and Methods 
Purification of AdoMet by CM-Sepharose Fast flow 
To obtain pure AdoMet for use in kinetic assays, a lower acid protocol than the Source 
15S purification (chapter 2.6) was used. This method allows the pure AdoMet to be 
used as a solution that consists of pooled AdoMet-containing fractions at a pH much 
closer to neutral than would result from the 1.0 M hydrochloric acid used in the elution 
gradient for the Source 15S, which is dried after pooling fractions to remove most of the 
hydrochloric acid, though is still highly acidic upon resolvating the dried AdoMet. A 
10/30 Tricorn column was packed with CM Sepharose fast flow resin (GE Healthcare), 
using a carboxymethyl functionalized weak cation exchange resin in an automated 
update of Chirpich.155 The column was equilibrated at a flow rate of ~2 mL/min with 900 
mL of 50 mM sodium acetate buffer, pH 5.0, then 800 mL of 5 mM sodium acetate 
buffer, pH 5.0. The higher concentration buffer equilibrates the resin in a lesser volume, 
while the second buffer is the lower ionic strength that the original method used. 50 mg 
of AdoMet chloride dihydrochloride salt (A7007, Sigma) is dissolved in ~2.2 mL of the 5 
mM sodium acetate buffer and loaded into a 2 mL loop. The AdoMet was run over the 
column using the 5 mM sodium acetate and washed for 1.5 column volumes and 
continued washing until the A255 returned to 25 mAU at around 3 CV. The AdoMet was 
then eluted by a step elution using 27.5mM hydrochloric acid, with fractions of 4 mL 
collected when the A255 was over 50 mAU. The AdoMet containing fractions were 
pooled and stored in at -20C until use, with the solution at pH 5 or slightly lower, as 
measured by pH paper, not requiring neutralization upon dilution into assay buffer as 
the ~pH 1 dried and dissolved AdoMet from Source 15S purification. 
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Purification of TylM1  
The TylM1 pET31 expression vector was used as supplied by the Holden laboratory, 
yielding a construct with an uncleavable C-terminal His-tag.96 For the extended 
expression necessary to produce fully deuterated protein in minimal media for neutron 
crystallography trials, the gene encoding the enzyme was moved to pET 24b using NdeI 
and XhoI, yielding the exact same construct within kanamycin resistant vector. This 
expression vector was also used to produce wild type, non-deuterated protein. The 
tyrosine 14 to phenylalanine, serine 120 to alanine and the Y14F S120A double mutant 
were introduced using Quikchange mutagenesis (Agilent). The tyrosine 14 to para-
aminophenylalanine mutant utilized Quikchange mutagenesis to introduce the amber 
(UAG) stop codon at that position, making use of an amber stop codon suppression 
system used previously to introduce the unnatural amino acid, but incorporated into the 
pDULE2 plasmid.84, 156 The natural proteins were all over expressed with 
chloramphenicol (50 µg/mL) and either ampicillin (100 µg/mL, for pET31 vectors) or 
kanamycin (100 µg/mL, for pET24 vectors) in 2XYT media and induced at ~0.6-1.0 
OD600 with 250 µM IPTG and grown overnight at 18°C. The protein incorporating the 
unnatural amino acid was overexpressed utilizing the pDULE2 pAF stop codon 
suppression system in BL21-AI cells with ampicillin (100 µg/mL) and spectinomycin 
(100 µg/mL), with induction at 18°C including 250uM IPTG, 0.2% arabinose, and 1 mM 
of the unnatural amino acid para-aminophenylalanine. All cultures were spun down at 
3800 rpm (H600A rotor) for 30 minutes, and cell pellets were resuspended in 50 mM 
sodium phosphate, pH 7.5, 500 mM sodium chloride. Resuspension was pooled and 
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aliquoted into 50 mL falcon tubes in aliquots containing roughly 1 L of cell culture and 
placed in the -80°C for storage. 
 Protein was purified by thawing the resuspended cell pellet and lysing by rocking 
at 4°C with lysozyme and HALT protease inhibitor cocktail (Roche). The resuspension 
was brought up to 60-70 mL of total volume with Buffer A (50 mM sodium phosphate, 
pH 7.5, 500 mM sodium chloride) before sonicating in a metal beaker 3-4 times for 1 
minute at ~90 W of power, allowing at least 30 seconds between sonicating to allow 
cooling. Lysate was centrifuged at 18,000 rpm (in a SS34 rotor), and decantate was 
filtered with 0.45 µm SFCA filters before loading onto the chromatography system. The 
filtered decantate was loaded onto a 4 mL TALON (Clontech) column that had been 
pre-equilibrated in Buffer A. The column was then washed with 5 column volumes of 
Buffer A before a 15 column volume gradient elution from Buffer A to Buffer B (50 mM 
sodium phosphate, pH 7.5, 500 mM sodium chloride, 300 mM imidazole). The TylM1 
containing fractions were concentrated and loaded onto gel filtration on a HiLoad 16/60 
Superdex S200 column (GE Healthcare). The buffer used for gel filtration was either 20 
mM sodium phosphate, pH 7-8, with 100 mM sodium chloride, or 20 mM sodium 
malonate, pH 7-7.6, with 100 mM sodium chloride for protein used in crystallization 
trials, while 20 mM Hepes, pH 7.5, with 100 mM sodium chloride was used for protein 
used in biochemical assays. 
Crystallization 
WT TylM1 was crystallized in 20% w/v PEG 5000 MME, 150 mM sodium malonate, pH 
7.0, 1% v/v isopropanol, and 12 mM barium chloride. The protein solution contained 18 
mg/mL TylM1, 5 mM AdoMet, and 5 mM dTDP-phenol, with the hanging drop set at 2:2 
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µL protein solution to well solution. Crystal was cryoprotected in 10% v/v ethylene 
glycol, 28% w/v PEG 5000 MME, 100 mM sodium chloride, 5 mM AdoMet, and 5 mM 
dTDP-phenol before flash freezing in liquid nitrogen. 
Mutant TylM1 enzymes were crystallized in 23-27% w/v PEG 3350, 100 mM 
Hepes, pH 7.3-7.7, 4.5-5.6 mM trimethylamine hydrochloride, 20 mM sodium malonate, 
and 1-1.25% isopropanol v/v. Hanging drops were 4:2 µL protein:precipitant for the 
Y14F, S120A, and Y14F S120A mutants and 2:2 µL for Y14pAF. The protein solutions 
all contained 5.0 mM AdoMet and 5.0 mM dTDP-phenol, with the protein concentrations 
for S120A and Y14F S120A at 18 mg/mL, Y14pAF at 12 mg/mL, and Y14F at 9 mg/mL. 
Crystals were cryoprotected using 10% v/v ethylene glycol in solutions similar to the 
precipitant used, and flash frozen in liquid nitrogen. 
 Data were collected on LS-CAT beamlines at the Advanced Photon Source at 
Argonne National Laboratory. HKL2000 was used to process and scale the data sets.141 
Molecular replacement was performed using Phaser142, using the WT 
TylM1•AdoMet•dTDP-phenol complex (3PFG)96  converted to poly-alanine and with 
ligands and waters removed as the search model for the wild type, Y14F and Y14F 
S120A structures, and a partially refined WT structure with ligands and waters removed 
and the mutation site modeled as an alanine for the search model for the Y14pAF and 
S120A structures. Coot143 was used for model building, and Phenix144 was used for 
refinement. Images for structural figures were generated using the PyMOL Molecular 
Graphics System, Schrödinger, LLC. 
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QM calculations 
Quantum mechanical binding energies were obtained by subtraction of the 
energies of the optimized monomers from the complex energy calculated using M06-
2X/6-31+G**. The counterpoise correction method was used to correct for basis set 
superposition error. Positions of hydrogen atoms were optimized, while other atoms 
were frozen in their crystallographic positions. 
Biochemical Assays 
 A continuous, coupled fluorescent assay was developed based on a previous 
method for a quenched coupled fluorescent assay, in which the product of methyl 
transfer S-adenosyl-L-homocysteine (AdoHcy or SAH) is hydrolyzed to produce 
adenosine and homocysteine.157 The homocysteine then reacts with a thiol-reactive 
dye, producing a fluorescent readout of methyltransferase activity. The SAH Hydrolase 
(SAHH) construct used previously was also used in this assay, with overexpression in 
2XYT with the addition of 100 µM IPTG at an OD600 of ~1 and grown at 37°C for 3 
hours. The cultures were pelleted, and the pellets resuspended in 10 mL of the 
hydrolase was lysed by rocking with lysozyme and HALT protease inhibitor cocktail 
(Roche) for at least 1 hour, brought up to 60 mL with hydrolase Buffer A (50 mM sodium 
phosphate, pH 7.5, 500 mM sodium chloride, with 10% v/v glycerol) and sonicated 3 
times for 1 minute at ~90 W, with at least 30 seconds between for cooling. Lysate was 
centrifuged at 18,000 rpm (SS34 rotor) for 30 minutes, and decantate was filtered with 
0.45 µm SFCA filters before loading onto the chromatography system. The filtered 
decantate was loaded onto a 4 mL TALON column (Clontech), washed with 5 column 
volumes of hydrolase Buffer A, and eluted with a 15 column volume gradient to 
82 
 
hydrolase Buffer B (50 mM sodium phosphate, pH 7.5, 500 mM sodium chloride, 300 
mM imidazole, with 10% v/v glycerol). Protein containing fractions were pooled in 10 
kDa dialysis tubing and cleaved with ~1.2 mg TEV protease overnight in 2 L of 20 mM 
sodium phosphate, pH 8.0, 35 mM sodium chloride, and 5 mM beta-mercaptoethanol. 
Cleavage solution was passed over a small TALON column (~1.5 mL, Clontech) to 
remove uncleaved protein and TEV protease before concentrating to load onto gel 
filtration on a HiLoad 16/60 Superdex S200 column (GE Healthcare). The gel filtration 
buffer used was 20 mM Hepes, pH 7.5, 100 mM sodium chloride. Protein containing 
fractions were pooled, aliquoted, and flash frozen in liquid nitrogen before storage in the 
-80°C freezer. 
ThioGlo (HC 9080, Berry and Associates) was used as the thiol-reactive dye over 
CME (HC 9097, Berry and Associates) even though CME has a greater fluorescent 
yield as CME exhibited an increasing background signal with time that was also 
dependent on AdoMet concentration.  The assay was performed in 100 mM Hepes 
(neutralized with sodium hydroxide), pH 7.5 as the buffer in black ProxiPlate-384 F Plus 
plates (PerkinElmer) with a final volume of 16 µL per well. The calibration curve was 0-
10 µM L-homocysteine (69453, Sigma-Aldrich) with SAHH present at the concentration 
used in the enzyme mix. Before initiation, the 384-well plate with 8 µL per well of either 
2X calibration curve or 2X enzyme mix was incubated at 37°C for at least 5 minutes, 
with the 2X AdoMet and ThioGlo solutions incubated in tubes. The assay was initiated 
with the addition of 8 µL of the AdoMet and ThioGlo solution by multichannel pipette, 
with ThioGlo at a final concentration of 25 µM. The pipette was a single-dispensing 20 
µL multichannel, with a slight mixing performed by pipetting up and down the combined 
83 
 
well solution upon addition. Fresh tips were used for every dispensing. The coupling 
enzyme, SAHH, was verified to not be rate limiting when used at 5 µM. Enzyme linearity 
was checked between 0 and 100 nM and points of 60, 80, and 100 nM showed good 
linearity (see Figure 4.5). Each point was run in quadruplicate, and the fluorescence 
was read on a Pherastar plate reader (BMG Labtech) using a 390 nm filter for excitation 
and a 505 nm filter for emission.  
 
Figure 4.5: Linearity of methyltransferase active as a function of WT TylM1 
concentration. 
TylM1 was used at 70 nM in further assays. The KM of dTDP-Quip3N was 
determined with wild type TylM1 and 1 mM AdoMet (Figure 4.6), and greater than 6-fold 
KM (150 µM) was used in the determination of the KM of AdoMet and the kcat value. Data 
was converted to concentration homocysteine produced using the initial slope and 
background of the calibration curve. Fluorescence was read every 45 seconds, and 
datapoints for 5.25 minutes were used to obtain the rate of homocysteine production, 
which was used to generate the points for the Michaelis-Menten curve to determine the 
KM of AdoMet and the kcat value for all enzymes. Prism software (Graphpad) was used 
to obtain all fits. 
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Figure 4.6: KM determination of dTDP-Quip3N with wild type TylM1.
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Chapter 5: 
Conclusions and Future Directions 
5.1 Conclusions 
Carbon-oxygen hydrogen (CH•••O) bonds and sulfur-oxygen (S•••O) chalcogen 
bonds to the S-adenosyl-L-methionine (AdoMet) sulfonium have been shown by these 
studies to be important features in binding and catalysis by AdoMet-dependent 
methyltransferases. These studies expand on previous work to show the importance of 
CH•••O hydrogen bonding to the methylene groups of AdoMet, which are also 
positioned proximal to the positively charged sulfur atom, similar to the methyl group. 
These positions are also able to engage in strong CH•••O hydrogen bonds, as the 
charge of the system has an influence on all three carbons connected to the sulfur.44 
The slight catalytic defects seen within TylM1 indicate that they may help align the SN2 
reaction in some methyltransferases. 
 The ability of waters to engage in CH•••O hydrogen bonding had been 
demonstrated in a study of neutron structures, in which the hydrogen positions are 
experimentally determined.33 CH•••O hydrogen bonding to MetH showed the ability of 
waters to engage in CH•••O hydrogen bonds with strong implications for binding 
AdoMet by this enzyme. MetH seemed to show no CH•••O hydrogen bonding to the 
protein, making it an outlier of the previous survey of AdoMet-bound 
methyltransferases.47 The active site of MetH is largely solvent exposed, and may 
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require some conformational changes to allow the methyl group to be transferred to the 
cobalamin cofactor.158, 159 This necessity to interface with a planar nucleophile dictates 
that the active site must be more open, making waters ideal, as they can rearrange 
more readily than sidechains, which are limited by the polypeptide. In this type of 
CH•••O hydrogen bond, there are still key protein sidechains, glutamates in the case of 
MetH, that act to polarize the waters and potentiate the interaction. In this sense, the 
glutamates may be thought of as facilitating these CH•••O hydrogen bonds as second 
shell interaction (i.e. not directly bonding), as the removal of the charge at those 
positions by mutation to glutamines greatly disrupts AdoMet binding, consistent with the 
removal of bonding seen in the study of other methyltransferases in this dissertation. 
Chalcogen bonding was found to play an important role in SET7/9, yet these 
interactions are not conserved across all AdoMet-dependent methyltransferases. This 
presents the opportunity for further study as to the differences between 
methyltransferases in which chalcogen bonds are present or absent. Study of a tyrosine 
within the glycine N-methyltransferase active site, which forms a chalcogen bond 
between the side chain hydroxyl group and the sulfur atom of AdoMet, also showed 
disruption of binding and catalysis upon mutation.110 This suggests an important role for 
chalcogen bonding in methyltransferases when this interaction is present. 
5.2 Future Directions 
TylM1, with high resolution crystal structures already solved by X-ray diffraction 
(Figure 5.1A), presents a unique opportunity to experimentally determine the methyl 
rotamer position, and therefore the geometries of the hydrogen bonds formed. To make 
use of the high resolution data already obtained, the Trievel laboratory has entered into 
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collaboration with the laboratory of Dr. Ho Leung Ng at Kansas State University. Dr. Ng 
is developing the HyPO method (Hydrogen atom Prediction and Observation). The 
method makes use of low level electron density within the maps, using three-fold 
averaging around the methyl group axis to determine the most probable position of the 
hydrogens in rotation. As the method is developed, there is hope that it can be applied 
to medium resolution electron density maps, allowing better determination of CH•••O 
distances and interaction angles through experimental placement of hydrogen positions 
within methyltransferase active sites, rather than the current inference based on C•••O 
distance. 
Figure 5.1: Structural determination of hydrogen positions in TylM1. 
Rendering of 2FO-FC density for AdoMet, tyrosine 14, and phenylalanine 118, with the 
map contoured at 1.5 sigma (A). A 1 hour test diffraction (B) on the IMAGINE detector 
at Oak Ridge National Laboratory of a hydrogenated TylM1 crystal (C) mounted in a 
1mm quartz capillary tube. A perdeuterated crystal of TylM1 (D), showing the smaller 
size and poorer morphology. 
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Another method for the structural determination of hydrogens in TylM1 is the use 
of neutron crystallography. Neutron crystallography has been very important in the 
study of CH•••O hydrogen bonding,32, 33 as neutrons readily diffract off hydrogen atoms, 
yielding experimental information on the atomic positions. Crystal trials with TylM1 
hydrogenated protein was able to produce very large crystals, which were back-soaked 
into perdeuterated precipitant solution and diffracted to about 6 Å in an initial test shot 
(Figure 5.1B,C). To decrease the incoherent scatter from 1H, and therefore background 
noise in the diffraction patterns, perdeuterated protein was overexpressed at Oak Ridge 
National Laboratory using a fermenter to get maximal growth out of a minimal media 
system utilizing feeding of perdeuterated glycerol. The perdeuterated protein was 
purified in hydrogenated buffers before exchange upon the final concentration of the 
protein before aliquoting and flash freezing. Initial crystal trials yielded large crystals, 
though the morphology was not as good as the hydrogenated protein (Figure 5.1D). The 
use of neutron crystallography represents a continuing point of the TylM1 work 
presented in this dissertation. 
Catechol O-Methyltransferase could act as a model system to explore many 
interactions important in methyltransferases and continue the work of this dissertation. 
Catechol O-Methyltransferase has acted as the foremost methyltransferase in which the 
origin of catalytic rate enhancement has been debated.100, 114 There have been multiple 
structures deposited in the Protein Data Bank,63, 160 allowing use of crystallographic 
coordinates for the creation of minimal model systems to be used in computational 
studies. There are active site CH•••O hydrogen bonds (Figure 5.2), though they do not 
represent sites accessible to bond disruption by removal of the oxygen acceptor through 
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mutation, as two of the hydrogen bond acceptors are backbone carbonyls, and the third 
is a nitro group on the inhibitor, important in the inhibitor structure. Further study of 
chalcogen bonding in COMT presents a great opportunity. The active site of COMT has 
a sulfur-sulfur chalcogen bond, in which the sulfur of a methionine sidechain is anti the 
methionyl methylene, acting as the electron donor, and is 0.3 Å shorter than the van der 
Waals distance for such an interaction. Mutation to canonical amino acids such as 
alanine, leucine, or isoleucine could be used to disrupt this interaction, though may not 
represent ideal substitutions due to the much smaller size of the side chain or the 
introduction of branching. Introduction of the noncanonical amino acid norleucine (Nle), 
which is an isostere of methionine in which the sulfur is replaced by a methylene 
carbon, could be used to form a less disruptive mutation of the COMT active site, with 
the use of a methionine or leucine auxotroph to introduce the noncanonical amino acid 
at that position.161 Exploration of the Met40Nle could further establish chalcogen 
bonding as an important interaction in the binding of AdoMet, either through binding 
studies by isothermal titration calorimetry to obtain the binding constant or the apparent 
affinity of the Michaelis constant (KM) obtained from kinetic assays. The effect on 
catalysis seen upon loss of the chalcogen bond may also provide information influential 
to the debate of the near attack conformation (NAC)119 versus the electrostatic 
preorganization114 with respect to the origin of the catalytic rate enhancement of COMT. 
The electrostatic preorganization model states that there is a preferential stabilization of 
the transition state, leading to catalysis, while the near attack conformation has been 
interpreted as the biasing of alignment of the substrates to a productive conformation by 
the binding of the reactant state. A large catalytic defect in the mutant may be favorably 
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explained by the near attack conformation, as the bond should be much stronger in the 
reactant state, which contains a sulfonium sulfur, than in the transition state, in which 
the sulfur is progressing towards the neutrality seen in the product S-
adenosylhomocysteine. 
 
Figure 5.2: Active site interactions in catechol O-methyltransferase. 
The active site of catechol O-methyltransferase (from 1VID)63 showing AdoMet (forest 
green), the dinitrocatechol inhibitor (cyan), the magnesium ion (green, shown as a 
sphere), and two active site residues methionine 40 and aspartate 141. CH•••O 
hydrogen bonds shown as orange dashes, an S•••S chalcogen bond shown as purple 
dashes (3.3 Å, combined van der Waals radii of 3.6 Å), and a C•••O tetrel bond shown 
as black dashes (2.6 Å, combined van der Waal radii of 3.25). 
  
The tetrel bond represents a new bonding interaction to probe in 
methyltransferases and is seen in the COMT active site when bound to AdoMet and an 
inhibitor dinitrocatechol. A tetrel bond is similar to the chalcogen and halogen bonds in 
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that it is a σ-antibonding interaction except with column 14 elements (C, Si, etc.). Similar 
to the chalcogen bond, it is increased in strength in a charged, sulfonium system, 
relative to an uncharged system,45 and it may represent the formation of a state like a 
pre-transition state, though the inhibitor bound does not allow catalysis. The energy of 
the tetrel interaction in COMT will be studied quantum mechanically, as disruption of 
this interaction chemically may not be feasible, due to multiple interactions that the 
inhibitor oxygen and AdoMet methyl form. Substitution for other inhibitors, such as the 
drug tolcapone, to change the strength of the interaction may also present challenges, 
as tolcapone has been cited as a poor substrate,162 with the possibility of turnover 
complicating any crystallographic or binding studies. SET7/9 may represent a more 
feasible system to study the tetrel interaction seen in COMT through the introduction of 
a TAF10 peptide capable of forming such a bond without reaction. The synthetic 
incorporation of 6-hydroxynorleucine, effectively substituting the lysine ε-amine group 
for a hydroxyl group, should present a nonreactive isostere that can be used in binding, 
crystallographic, and computational studies in the well-studied SET7/9 model system. 
Though they have been studied for approaching 60 years,64 AdoMet-dependent 
methyltransferases continue to be a field open to further research. This dissertation 
explored CH•••O hydrogen bonding to the methyl and methylene carbons of AdoMet,  
and an S•••O chalcogen bond to the sulfonium sulfur, and further study of these 
interactions will hopefully yield trends useful in understanding and classifying active site 
interactions in these enzymes. Expansion of study of the AdoMet-dependent 
methyltransferases to tetrel bonding and other interactions should bring the field ever 
92 
 
closer to an understanding as to how methyltransferases use their active sites to 
facilitate the transfer of the methyl group of AdoMet. 
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